id	sid	tid	token	lemma	pos
njb-40	1	1	nepal	nepal	ADJ
njb-40	1	2	journal	journal	NOUN
njb-40	1	3	of	of	ADP
njb-40	1	4	biotechnology	biotechnology	NOUN
njb-40	1	5	.	.	PUNCT
njb-40	2	1	d	d	X
njb-40	2	2	e	e	PROPN
njb-40	2	3	c	c	PROPN
njb-40	2	4	.	.	PUNCT
njb-40	3	1	2	2	NUM
njb-40	3	2	0	0	NUM
njb-40	3	3	1	1	NUM
njb-40	3	4	5	5	NUM
njb-40	3	5	vol	vol	NOUN
njb-40	3	6	.	.	PUNCT
njb-40	4	1	3	3	NUM
njb-40	4	2	,	,	PUNCT
njb-40	4	3	no	no	INTJ
njb-40	4	4	.	.	PUNCT
njb-40	5	1	1:10	1:10	NUM
njb-40	5	2	-	-	SYM
njb-40	5	3	14	14	NUM
njb-40	5	4	issn	issn	PROPN
njb-40	5	5	2091	2091	NUM
njb-40	5	6	-	-	SYM
njb-40	5	7	1130	1130	NUM
njb-40	5	8	(	(	PUNCT
njb-40	5	9	print	print	NOUN
njb-40	5	10	)	)	PUNCT
njb-40	5	11	/issn	/issn	PUNCT
njb-40	5	12	2467	2467	NUM
njb-40	5	13	-	-	SYM
njb-40	5	14	9319	9319	NUM
njb-40	5	15	(	(	PUNCT
njb-40	5	16	online	online	ADJ
njb-40	5	17	)	)	PUNCT
njb-40	5	18	original	original	ADJ
njb-40	5	19	research	research	NOUN
njb-40	5	20	article	article	NOUN
njb-40	5	21	©	©	PROPN
njb-40	5	22	njb	njb	PROPN
njb-40	5	23	,	,	PUNCT
njb-40	5	24	biotechnology	biotechnology	NOUN
njb-40	5	25	society	society	NOUN
njb-40	5	26	of	of	ADP
njb-40	5	27	nepal	nepal	ADJ
njb-40	5	28	10	10	NUM
njb-40	5	29	nepjol.info/index.php/njb	nepjol.info/index.php/njb	ADJ
njb-40	5	30	doxorubicin	doxorubicin	PROPN
njb-40	5	31	induced	induce	VERB
njb-40	5	32	histomorphometric	histomorphometric	ADJ
njb-40	5	33	changes	change	NOUN
njb-40	5	34	in	in	ADP
njb-40	5	35	testes	testis	NOUN
njb-40	5	36	of	of	ADP
njb-40	5	37	albino	albino	NOUN
njb-40	5	38	rats	rat	NOUN
njb-40	5	39	surendra	surendra	PROPN
njb-40	5	40	kumar	kumar	PROPN
njb-40	5	41	sah1	sah1	PROPN
njb-40	5	42	,	,	PUNCT
njb-40	5	43	saroj	saroj	PROPN
njb-40	5	44	khatiwada2	khatiwada2	PROPN
njb-40	5	45	*	*	PROPN
njb-40	5	46	,	,	PUNCT
njb-40	5	47	deepak	deepak	ADJ
njb-40	5	48	chaudhary1	chaudhary1	PROPN
njb-40	5	49	,	,	PUNCT
njb-40	5	50	chandra	chandra	PROPN
njb-40	5	51	bhushan	bhushan	PROPN
njb-40	5	52	jha3	jha3	PROPN
njb-40	5	53	,	,	PUNCT
njb-40	5	54	soumya	soumya	PROPN
njb-40	5	55	bhattacharya3	bhattacharya3	PROPN
njb-40	5	56	1department	1department	NUM
njb-40	5	57	of	of	ADP
njb-40	5	58	anatomy	anatomy	NOUN
njb-40	5	59	,	,	PUNCT
njb-40	5	60	nobel	nobel	PROPN
njb-40	5	61	medical	medical	PROPN
njb-40	5	62	college	college	PROPN
njb-40	5	63	,	,	PUNCT
njb-40	5	64	biratnagar	biratnagar	ADJ
njb-40	5	65	,	,	PUNCT
njb-40	5	66	nepal	nepal	ADJ
njb-40	5	67	2department	2department	NUM
njb-40	5	68	of	of	ADP
njb-40	5	69	biochemistry	biochemistry	NOUN
njb-40	5	70	,	,	PUNCT
njb-40	5	71	modern	modern	ADJ
njb-40	5	72	technical	technical	ADJ
njb-40	5	73	college	college	PROPN
njb-40	5	74	,	,	PUNCT
njb-40	5	75	lalitpur	lalitpur	PROPN
njb-40	5	76	,	,	PUNCT
njb-40	5	77	nepal	nepal	ADJ
njb-40	5	78	3department	3department	NUM
njb-40	5	79	of	of	ADP
njb-40	5	80	human	human	ADJ
njb-40	5	81	anatomy	anatomy	NOUN
njb-40	5	82	,	,	PUNCT
njb-40	5	83	b	b	NOUN
njb-40	5	84	p	p	PROPN
njb-40	5	85	koirala	koirala	PROPN
njb-40	5	86	institute	institute	PROPN
njb-40	5	87	of	of	ADP
njb-40	5	88	health	health	PROPN
njb-40	5	89	sciences	sciences	PROPN
njb-40	5	90	,	,	PUNCT
njb-40	5	91	dharan	dharan	PROPN
njb-40	5	92	,	,	PUNCT
njb-40	5	93	nepal	nepal	ADJ
njb-40	5	94	abstract	abstract	ADJ
njb-40	5	95	anticancer	anticancer	NOUN
njb-40	5	96	drugs	drug	NOUN
njb-40	5	97	like	like	ADP
njb-40	5	98	doxorubicin	doxorubicin	PROPN
njb-40	5	99	have	have	AUX
njb-40	5	100	been	be	AUX
njb-40	5	101	found	find	VERB
njb-40	5	102	to	to	PART
njb-40	5	103	affect	affect	VERB
njb-40	5	104	male	male	ADJ
njb-40	5	105	gonads	gonad	NOUN
njb-40	5	106	thereby	thereby	ADV
njb-40	5	107	leading	lead	VERB
njb-40	5	108	to	to	ADP
njb-40	5	109	infertility	infertility	NOUN
njb-40	5	110	.	.	PUNCT
njb-40	6	1	this	this	DET
njb-40	6	2	study	study	NOUN
njb-40	6	3	was	be	AUX
njb-40	6	4	conducted	conduct	VERB
njb-40	6	5	to	to	PART
njb-40	6	6	evaluate	evaluate	VERB
njb-40	6	7	the	the	DET
njb-40	6	8	effects	effect	NOUN
njb-40	6	9	of	of	ADP
njb-40	6	10	doxorubicin	doxorubicin	PROPN
njb-40	6	11	over	over	ADP
njb-40	6	12	short	short	ADJ
njb-40	6	13	,	,	PUNCT
njb-40	6	14	mid	mid	ADJ
njb-40	6	15	and	and	CCONJ
njb-40	6	16	long	long	ADJ
njb-40	6	17	term	term	NOUN
njb-40	6	18	on	on	ADP
njb-40	6	19	testes	testis	NOUN
njb-40	6	20	of	of	ADP
njb-40	6	21	male	male	ADJ
njb-40	6	22	albino	albino	NOUN
njb-40	6	23	rats	rat	NOUN
njb-40	6	24	.	.	PUNCT
njb-40	7	1	sixty	sixty	NUM
njb-40	7	2	male	male	ADJ
njb-40	7	3	albino	albino	NOUN
njb-40	7	4	rats	rat	NOUN
njb-40	7	5	aged	age	VERB
njb-40	7	6	6	6	NUM
njb-40	7	7	-	-	SYM
njb-40	7	8	8	8	NUM
njb-40	7	9	weeks	week	NOUN
njb-40	7	10	were	be	AUX
njb-40	7	11	taken	take	VERB
njb-40	7	12	for	for	ADP
njb-40	7	13	study	study	NOUN
njb-40	7	14	.	.	PUNCT
njb-40	8	1	the	the	DET
njb-40	8	2	rats	rat	NOUN
njb-40	8	3	were	be	AUX
njb-40	8	4	randomly	randomly	ADV
njb-40	8	5	divided	divide	VERB
njb-40	8	6	into	into	ADP
njb-40	8	7	3	3	NUM
njb-40	8	8	groups	group	NOUN
njb-40	8	9	of	of	ADP
njb-40	8	10	experimental	experimental	ADJ
njb-40	8	11	(	(	PUNCT
njb-40	8	12	each	each	DET
njb-40	8	13	group	group	NOUN
njb-40	8	14	containing	contain	VERB
njb-40	8	15	10	10	NUM
njb-40	8	16	rats	rat	NOUN
njb-40	8	17	)	)	PUNCT
njb-40	8	18	and	and	CCONJ
njb-40	8	19	3	3	NUM
njb-40	8	20	groups	group	NOUN
njb-40	8	21	of	of	ADP
njb-40	8	22	control	control	NOUN
njb-40	8	23	(	(	PUNCT
njb-40	8	24	each	each	DET
njb-40	8	25	group	group	NOUN
njb-40	8	26	containing	contain	VERB
njb-40	8	27	10	10	NUM
njb-40	8	28	rats	rat	NOUN
njb-40	8	29	)	)	PUNCT
njb-40	8	30	.	.	PUNCT
njb-40	9	1	the	the	DET
njb-40	9	2	experimental	experimental	ADJ
njb-40	9	3	groups	group	NOUN
njb-40	9	4	were	be	AUX
njb-40	9	5	given	give	VERB
njb-40	9	6	a	a	DET
njb-40	9	7	single	single	ADJ
njb-40	9	8	dose	dose	NOUN
njb-40	9	9	of	of	ADP
njb-40	9	10	doxorubicin	doxorubicin	PROPN
njb-40	9	11	i.e.	i.e.	X
njb-40	9	12	10	10	NUM
njb-40	9	13	mg	mg	PROPN
njb-40	9	14	/	/	SYM
njb-40	9	15	kg	kg	PROPN
njb-40	9	16	body	body	NOUN
njb-40	9	17	weight	weight	NOUN
njb-40	9	18	intra	intra	NOUN
njb-40	9	19	-	-	ADJ
njb-40	9	20	peritoneally	peritoneally	ADV
njb-40	9	21	and	and	CCONJ
njb-40	9	22	sacrificed	sacrifice	VERB
njb-40	9	23	after	after	ADP
njb-40	9	24	3	3	NUM
njb-40	9	25	different	different	ADJ
njb-40	9	26	duration	duration	NOUN
njb-40	9	27	for	for	ADP
njb-40	9	28	each	each	DET
njb-40	9	29	group	group	NOUN
njb-40	9	30	(	(	PUNCT
njb-40	9	31	second	second	ADJ
njb-40	9	32	week	week	NOUN
njb-40	9	33	,	,	PUNCT
njb-40	9	34	eighth	eighth	ADJ
njb-40	9	35	week	week	NOUN
njb-40	9	36	and	and	CCONJ
njb-40	9	37	sixteenth	sixteenth	ADJ
njb-40	9	38	week	week	NOUN
njb-40	9	39	)	)	PUNCT
njb-40	9	40	.	.	PUNCT
njb-40	10	1	all	all	DET
njb-40	10	2	rats	rat	NOUN
njb-40	10	3	under	under	ADP
njb-40	10	4	3	3	NUM
njb-40	10	5	control	control	NOUN
njb-40	10	6	groups	group	NOUN
njb-40	10	7	were	be	AUX
njb-40	10	8	given	give	VERB
njb-40	10	9	a	a	DET
njb-40	10	10	single	single	ADJ
njb-40	10	11	intra	intra	ADJ
njb-40	10	12	-	-	ADJ
njb-40	10	13	peritoneal	peritoneal	ADJ
njb-40	10	14	dose	dose	NOUN
njb-40	10	15	of	of	ADP
njb-40	10	16	2.5	2.5	NUM
njb-40	10	17	ml	ml	PROPN
njb-40	10	18	/	/	SYM
njb-40	10	19	kg	kg	NOUN
njb-40	10	20	body	body	NOUN
njb-40	10	21	weight	weight	NOUN
njb-40	10	22	normal	normal	ADJ
njb-40	10	23	saline	saline	NOUN
njb-40	10	24	and	and	CCONJ
njb-40	10	25	sacrificed	sacrifice	VERB
njb-40	10	26	with	with	ADP
njb-40	10	27	their	their	PRON
njb-40	10	28	respective	respective	ADJ
njb-40	10	29	experimental	experimental	ADJ
njb-40	10	30	groups	group	NOUN
njb-40	10	31	.	.	PUNCT
njb-40	11	1	significant	significant	ADJ
njb-40	11	2	difference	difference	NOUN
njb-40	11	3	in	in	ADP
njb-40	11	4	diameters	diameter	NOUN
njb-40	11	5	(	(	PUNCT
njb-40	11	6	p=0.029	p=0.029	NOUN
njb-40	11	7	)	)	PUNCT
njb-40	11	8	and	and	CCONJ
njb-40	11	9	cross	cross	ADJ
njb-40	11	10	-	-	ADJ
njb-40	11	11	sectional	sectional	ADJ
njb-40	11	12	area	area	NOUN
njb-40	11	13	(	(	PUNCT
njb-40	11	14	p=0.028	p=0.028	NOUN
njb-40	11	15	)	)	PUNCT
njb-40	11	16	of	of	ADP
njb-40	11	17	seminiferous	seminiferous	ADJ
njb-40	11	18	tubules	tubule	NOUN
njb-40	11	19	was	be	AUX
njb-40	11	20	observed	observe	VERB
njb-40	11	21	between	between	ADP
njb-40	11	22	short	short	ADJ
njb-40	11	23	term	term	NOUN
njb-40	11	24	experimental	experimental	ADJ
njb-40	11	25	and	and	CCONJ
njb-40	11	26	short	short	ADJ
njb-40	11	27	term	term	NOUN
njb-40	11	28	control	control	NOUN
njb-40	11	29	rats	rat	NOUN
njb-40	11	30	.	.	PUNCT
njb-40	12	1	for	for	ADP
njb-40	12	2	both	both	PRON
njb-40	12	3	between	between	ADP
njb-40	12	4	midterm	midterm	NOUN
njb-40	12	5	experimental	experimental	ADJ
njb-40	12	6	and	and	CCONJ
njb-40	12	7	midterm	midterm	NOUN
njb-40	12	8	control	control	NOUN
njb-40	12	9	group	group	NOUN
njb-40	12	10	,	,	PUNCT
njb-40	12	11	and	and	CCONJ
njb-40	12	12	between	between	ADP
njb-40	12	13	long	long	ADJ
njb-40	12	14	term	term	NOUN
njb-40	12	15	experimental	experimental	ADJ
njb-40	12	16	and	and	CCONJ
njb-40	12	17	long	long	ADJ
njb-40	12	18	term	term	NOUN
njb-40	12	19	control	control	NOUN
njb-40	12	20	group	group	NOUN
njb-40	12	21	,	,	PUNCT
njb-40	12	22	a	a	DET
njb-40	12	23	significant	significant	ADJ
njb-40	12	24	difference	difference	NOUN
njb-40	12	25	in	in	ADP
njb-40	12	26	right	right	ADJ
njb-40	12	27	testis	testis	NOUN
njb-40	12	28	weight	weight	NOUN
njb-40	12	29	(	(	PUNCT
njb-40	12	30	p<0.001	p<0.001	NUM
njb-40	12	31	for	for	ADP
njb-40	12	32	both	both	PRON
njb-40	12	33	)	)	PUNCT
njb-40	12	34	,	,	PUNCT
njb-40	12	35	left	leave	VERB
njb-40	12	36	testis	testis	NOUN
njb-40	12	37	weight	weight	NOUN
njb-40	12	38	(	(	PUNCT
njb-40	12	39	p<0.001	p<0.001	NUM
njb-40	12	40	for	for	ADP
njb-40	12	41	both	both	PRON
njb-40	12	42	)	)	PUNCT
njb-40	12	43	,	,	PUNCT
njb-40	12	44	volume	volume	NOUN
njb-40	12	45	of	of	ADP
njb-40	12	46	testis	testis	NOUN
njb-40	12	47	(	(	PUNCT
njb-40	12	48	p<0.001	p<0.001	ADJ
njb-40	12	49	and	and	CCONJ
njb-40	12	50	p=0.038	p=0.038	NOUN
njb-40	12	51	)	)	PUNCT
njb-40	12	52	,	,	PUNCT
njb-40	12	53	diameter	diameter	NOUN
njb-40	12	54	(	(	PUNCT
njb-40	12	55	p<0.001	p<0.001	NUM
njb-40	12	56	for	for	ADP
njb-40	12	57	both	both	PRON
njb-40	12	58	)	)	PUNCT
njb-40	12	59	and	and	CCONJ
njb-40	12	60	area	area	NOUN
njb-40	12	61	(	(	PUNCT
njb-40	12	62	p<0.001	p<0.001	VERB
njb-40	12	63	for	for	ADP
njb-40	12	64	both	both	PRON
njb-40	12	65	)	)	PUNCT
njb-40	12	66	of	of	ADP
njb-40	12	67	seminiferous	seminiferous	ADJ
njb-40	12	68	tubules	tubule	NOUN
njb-40	12	69	was	be	AUX
njb-40	12	70	observed	observe	VERB
njb-40	12	71	.	.	PUNCT
njb-40	13	1	as	as	SCONJ
njb-40	13	2	compared	compare	VERB
njb-40	13	3	to	to	ADP
njb-40	13	4	short	short	ADJ
njb-40	13	5	term	term	NOUN
njb-40	13	6	experimental	experimental	ADJ
njb-40	13	7	group	group	NOUN
njb-40	13	8	,	,	PUNCT
njb-40	13	9	midterm	midterm	NOUN
njb-40	13	10	experimental	experimental	ADJ
njb-40	13	11	group	group	NOUN
njb-40	13	12	and	and	CCONJ
njb-40	13	13	long	long	ADJ
njb-40	13	14	term	term	NOUN
njb-40	13	15	experimental	experimental	ADJ
njb-40	13	16	group	group	NOUN
njb-40	13	17	had	have	VERB
njb-40	13	18	significantly	significantly	ADV
njb-40	13	19	lower	low	ADJ
njb-40	13	20	right	right	ADJ
njb-40	13	21	testis	testis	NOUN
njb-40	13	22	weight	weight	NOUN
njb-40	13	23	(	(	PUNCT
njb-40	13	24	p<0.001	p<0.001	NUM
njb-40	13	25	for	for	ADP
njb-40	13	26	both	both	PRON
njb-40	13	27	)	)	PUNCT
njb-40	13	28	,	,	PUNCT
njb-40	13	29	left	leave	VERB
njb-40	13	30	testis	testis	NOUN
njb-40	13	31	weight	weight	NOUN
njb-40	13	32	(	(	PUNCT
njb-40	13	33	p<0.001	p<0.001	NUM
njb-40	13	34	for	for	ADP
njb-40	13	35	both	both	PRON
njb-40	13	36	)	)	PUNCT
njb-40	13	37	,	,	PUNCT
njb-40	13	38	diameter	diameter	NOUN
njb-40	13	39	of	of	ADP
njb-40	13	40	seminiferous	seminiferous	ADJ
njb-40	13	41	tubule	tubule	NOUN
njb-40	13	42	(	(	PUNCT
njb-40	13	43	p<0.001	p<0.001	VERB
njb-40	13	44	for	for	ADP
njb-40	13	45	both	both	PRON
njb-40	13	46	)	)	PUNCT
njb-40	13	47	and	and	CCONJ
njb-40	13	48	cross	cross	ADJ
njb-40	13	49	-	-	ADJ
njb-40	13	50	sectional	sectional	ADJ
njb-40	13	51	area	area	NOUN
njb-40	13	52	of	of	ADP
njb-40	13	53	seminiferous	seminiferous	ADJ
njb-40	13	54	tubule	tubule	NOUN
njb-40	13	55	(	(	PUNCT
njb-40	13	56	p<0.001	p<0.001	NOUN
njb-40	13	57	both	both	PRON
njb-40	13	58	)	)	PUNCT
njb-40	13	59	.	.	PUNCT
njb-40	14	1	cross	cros	NOUN
njb-40	14	2	-	-	NOUN
njb-40	14	3	sections	section	NOUN
njb-40	14	4	of	of	ADP
njb-40	14	5	the	the	DET
njb-40	14	6	seminiferous	seminiferous	ADJ
njb-40	14	7	tubules	tubule	NOUN
njb-40	14	8	of	of	ADP
njb-40	14	9	all	all	DET
njb-40	14	10	the	the	DET
njb-40	14	11	control	control	NOUN
njb-40	14	12	groups	group	NOUN
njb-40	14	13	had	have	VERB
njb-40	14	14	normal	normal	ADJ
njb-40	14	15	architecture	architecture	NOUN
njb-40	14	16	.	.	PUNCT
njb-40	15	1	however	however	ADV
njb-40	15	2	,	,	PUNCT
njb-40	15	3	there	there	PRON
njb-40	15	4	was	be	VERB
njb-40	15	5	progressive	progressive	ADJ
njb-40	15	6	destruction	destruction	NOUN
njb-40	15	7	of	of	ADP
njb-40	15	8	seminiferous	seminiferous	ADJ
njb-40	15	9	tubules	tubule	NOUN
njb-40	15	10	structure	structure	NOUN
njb-40	15	11	across	across	ADP
njb-40	15	12	the	the	DET
njb-40	15	13	experimental	experimental	ADJ
njb-40	15	14	groups	group	NOUN
njb-40	15	15	.	.	PUNCT
njb-40	16	1	doxorubicin	doxorubicin	PROPN
njb-40	16	2	has	have	VERB
njb-40	16	3	deleterious	deleterious	ADJ
njb-40	16	4	effect	effect	NOUN
njb-40	16	5	on	on	ADP
njb-40	16	6	seminiferous	seminiferous	ADJ
njb-40	16	7	tubules	tubule	NOUN
njb-40	16	8	of	of	ADP
njb-40	16	9	albino	albino	ADJ
njb-40	16	10	rat	rat	NOUN
njb-40	16	11	testis	testis	PROPN
njb-40	16	12	.	.	PUNCT
njb-40	17	1	key	key	ADJ
njb-40	17	2	words	word	NOUN
njb-40	17	3	:	:	PUNCT
njb-40	17	4	doxorubicin	doxorubicin	PROPN
njb-40	17	5	,	,	PUNCT
njb-40	17	6	histomorphometry	histomorphometry	PROPN
njb-40	17	7	,	,	PUNCT
njb-40	17	8	seminiferous	seminiferous	ADJ
njb-40	17	9	tubule	tubule	NOUN
njb-40	17	10	,	,	PUNCT
njb-40	17	11	albino	albino	NOUN
njb-40	17	12	rat	rat	NOUN
njb-40	17	13	*	*	VERB
njb-40	17	14	corresponding	correspond	VERB
njb-40	17	15	author	author	NOUN
njb-40	17	16	email	email	NOUN
njb-40	17	17	:	:	PUNCT
njb-40	17	18	khatiwadasaroj22@gmail.com	khatiwadasaroj22@gmail.com	X
njb-40	17	19	introduction	introduction	PROPN
njb-40	17	20	doxorubicin	doxorubicin	PROPN
njb-40	17	21	,	,	PUNCT
njb-40	17	22	also	also	ADV
njb-40	17	23	known	know	VERB
njb-40	17	24	as	as	ADP
njb-40	17	25	hydroxyd	hydroxyd	PROPN
njb-40	17	26	-	-	PUNCT
njb-40	17	27	aunorubicin	aunorubicin	PROPN
njb-40	17	28	,	,	PUNCT
njb-40	17	29	is	be	AUX
njb-40	17	30	a	a	DET
njb-40	17	31	drug	drug	NOUN
njb-40	17	32	used	use	VERB
njb-40	17	33	in	in	ADP
njb-40	17	34	cancer	cancer	NOUN
njb-40	17	35	chemotherapy	chemotherapy	NOUN
njb-40	17	36	.	.	PUNCT
njb-40	18	1	it	it	PRON
njb-40	18	2	is	be	AUX
njb-40	18	3	highly	highly	ADV
njb-40	18	4	effective	effective	ADJ
njb-40	18	5	in	in	ADP
njb-40	18	6	many	many	ADJ
njb-40	18	7	human	human	ADJ
njb-40	18	8	tumors	tumor	NOUN
njb-40	18	9	and	and	CCONJ
njb-40	18	10	is	be	AUX
njb-40	18	11	currently	currently	ADV
njb-40	18	12	the	the	DET
njb-40	18	13	first	first	ADJ
njb-40	18	14	line	line	NOUN
njb-40	18	15	anti	anti	ADJ
njb-40	18	16	-	-	ADJ
njb-40	18	17	cancer	cancer	ADJ
njb-40	18	18	drug	drug	NOUN
njb-40	18	19	in	in	ADP
njb-40	18	20	many	many	ADJ
njb-40	18	21	chemoresponsive	chemoresponsive	ADJ
njb-40	18	22	tumors	tumor	NOUN
njb-40	18	23	such	such	ADJ
njb-40	18	24	as	as	ADP
njb-40	18	25	ovarian	ovarian	ADJ
njb-40	18	26	cancers	cancer	NOUN
njb-40	18	27	,	,	PUNCT
njb-40	18	28	breast	breast	NOUN
njb-40	18	29	cancers	cancer	NOUN
njb-40	18	30	and	and	CCONJ
njb-40	18	31	lymphomas	lymphoma	NOUN
njb-40	18	32	[	[	X
njb-40	18	33	1	1	NUM
njb-40	18	34	]	]	PUNCT
njb-40	18	35	.	.	PUNCT
njb-40	19	1	the	the	DET
njb-40	19	2	clinical	clinical	ADJ
njb-40	19	3	use	use	NOUN
njb-40	19	4	of	of	ADP
njb-40	19	5	doxorubicin	doxorubicin	PROPN
njb-40	19	6	can	can	AUX
njb-40	19	7	be	be	AUX
njb-40	19	8	viewed	view	VERB
njb-40	19	9	as	as	ADP
njb-40	19	10	double	double	ADV
njb-40	19	11	edged	edge	VERB
njb-40	19	12	sword	sword	NOUN
njb-40	19	13	.	.	PUNCT
njb-40	20	1	on	on	ADP
njb-40	20	2	one	one	NUM
njb-40	20	3	hand	hand	NOUN
njb-40	20	4	,	,	PUNCT
njb-40	20	5	doxorubicin	doxorubicin	PROPN
njb-40	20	6	plays	play	VERB
njb-40	20	7	an	an	DET
njb-40	20	8	undisputed	undisputed	ADJ
njb-40	20	9	key	key	ADJ
njb-40	20	10	role	role	NOUN
njb-40	20	11	in	in	ADP
njb-40	20	12	the	the	DET
njb-40	20	13	treatment	treatment	NOUN
njb-40	20	14	of	of	ADP
njb-40	20	15	many	many	ADJ
njb-40	20	16	neoplastic	neoplastic	ADJ
njb-40	20	17	diseases	disease	NOUN
njb-40	20	18	;	;	PUNCT
njb-40	20	19	on	on	ADP
njb-40	20	20	the	the	DET
njb-40	20	21	other	other	ADJ
njb-40	20	22	hand	hand	NOUN
njb-40	20	23	,	,	PUNCT
njb-40	20	24	chronic	chronic	PROPN
njb-40	20	25	administration	administration	NOUN
njb-40	20	26	of	of	ADP
njb-40	20	27	doxorubicin	doxorubicin	PROPN
njb-40	20	28	induces	induce	VERB
njb-40	20	29	organ	organ	NOUN
njb-40	20	30	toxicity	toxicity	NOUN
njb-40	20	31	particularly	particularly	ADV
njb-40	20	32	testicular	testicular	NOUN
njb-40	20	33	injury	injury	NOUN
njb-40	20	34	[	[	NOUN
njb-40	20	35	2	2	NUM
njb-40	20	36	]	]	PUNCT
njb-40	20	37	.	.	PUNCT
njb-40	21	1	previous	previous	ADJ
njb-40	21	2	investigations	investigation	NOUN
njb-40	21	3	indicated	indicate	VERB
njb-40	21	4	that	that	SCONJ
njb-40	21	5	doxorubicin	doxorubicin	PROPN
njb-40	21	6	has	have	VERB
njb-40	21	7	the	the	DET
njb-40	21	8	ability	ability	NOUN
njb-40	21	9	to	to	PART
njb-40	21	10	induce	induce	VERB
njb-40	21	11	mutations	mutation	NOUN
njb-40	21	12	and	and	CCONJ
njb-40	21	13	chromosomal	chromosomal	ADJ
njb-40	21	14	aberrations	aberration	NOUN
njb-40	21	15	in	in	ADP
njb-40	21	16	normal	normal	ADJ
njb-40	21	17	and	and	CCONJ
njb-40	21	18	malignant	malignant	ADJ
njb-40	21	19	cells	cell	NOUN
njb-40	21	20	in	in	ADP
njb-40	21	21	addition	addition	NOUN
njb-40	21	22	to	to	ADP
njb-40	21	23	a	a	DET
njb-40	21	24	wide	wide	ADJ
njb-40	21	25	variety	variety	NOUN
njb-40	21	26	of	of	ADP
njb-40	21	27	toxic	toxic	ADJ
njb-40	21	28	side	side	NOUN
njb-40	21	29	effects	effect	NOUN
njb-40	21	30	on	on	ADP
njb-40	21	31	organs	organ	NOUN
njb-40	21	32	like	like	ADP
njb-40	21	33	testes	testis	NOUN
njb-40	21	34	[	[	PUNCT
njb-40	21	35	3	3	NUM
njb-40	21	36	]	]	X
njb-40	21	37	.	.	PUNCT
njb-40	22	1	doxorubicin	doxorubicin	PROPN
njb-40	22	2	is	be	AUX
njb-40	22	3	said	say	VERB
njb-40	22	4	to	to	PART
njb-40	22	5	alter	alter	VERB
njb-40	22	6	sperm	sperm	NOUN
njb-40	22	7	development	development	NOUN
njb-40	22	8	,	,	PUNCT
njb-40	22	9	production	production	NOUN
njb-40	22	10	,	,	PUNCT
njb-40	22	11	structural	structural	ADJ
njb-40	22	12	integrity	integrity	NOUN
njb-40	22	13	and	and	CCONJ
njb-40	22	14	motility	motility	NOUN
njb-40	22	15	rates	rate	NOUN
njb-40	22	16	in	in	ADP
njb-40	22	17	association	association	NOUN
njb-40	22	18	with	with	ADP
njb-40	22	19	increased	increase	VERB
njb-40	22	20	cellular	cellular	ADJ
njb-40	22	21	apoptosis	apoptosis	NOUN
njb-40	22	22	in	in	ADP
njb-40	22	23	spermatogonia	spermatogonia	NOUN
njb-40	22	24	and	and	CCONJ
njb-40	22	25	spermocyte	spermocyte	NOUN
njb-40	22	26	[	[	PUNCT
njb-40	22	27	4	4	NUM
njb-40	22	28	]	]	PUNCT
njb-40	22	29	.	.	PUNCT
njb-40	23	1	the	the	DET
njb-40	23	2	reduction	reduction	NOUN
njb-40	23	3	of	of	ADP
njb-40	23	4	oxidative	oxidative	ADJ
njb-40	23	5	dna	dna	PROPN
njb-40	23	6	damage	damage	NOUN
njb-40	23	7	by	by	ADP
njb-40	23	8	antioxidants	antioxidant	NOUN
njb-40	23	9	has	have	AUX
njb-40	23	10	been	be	AUX
njb-40	23	11	evaluated	evaluate	VERB
njb-40	23	12	as	as	ADP
njb-40	23	13	a	a	DET
njb-40	23	14	chemotherapeutic	chemotherapeutic	NOUN
njb-40	23	15	approach	approach	NOUN
njb-40	23	16	for	for	ADP
njb-40	23	17	reducing	reduce	VERB
njb-40	23	18	damage	damage	NOUN
njb-40	23	19	caused	cause	VERB
njb-40	23	20	by	by	ADP
njb-40	23	21	chemotherapy	chemotherapy	NOUN
njb-40	23	22	agents	agent	NOUN
njb-40	23	23	such	such	ADJ
njb-40	23	24	as	as	ADP
njb-40	23	25	doxorubicin	doxorubicin	PROPN
njb-40	23	26	[	[	PUNCT
njb-40	23	27	5	5	NUM
njb-40	23	28	]	]	X
njb-40	23	29	.	.	PUNCT
njb-40	24	1	damage	damage	NOUN
njb-40	24	2	to	to	ADP
njb-40	24	3	the	the	DET
njb-40	24	4	testicular	testicular	NOUN
njb-40	24	5	germinal	germinal	ADJ
njb-40	24	6	epithelium	epithelium	NOUN
njb-40	24	7	is	be	AUX
njb-40	24	8	a	a	DET
njb-40	24	9	potential	potential	ADJ
njb-40	24	10	side	side	NOUN
njb-40	24	11	effect	effect	NOUN
njb-40	24	12	of	of	ADP
njb-40	24	13	cancer	cancer	NOUN
njb-40	24	14	therapy	therapy	NOUN
njb-40	24	15	,	,	PUNCT
njb-40	24	16	and	and	CCONJ
njb-40	24	17	is	be	AUX
njb-40	24	18	of	of	ADP
njb-40	24	19	particular	particular	ADJ
njb-40	24	20	concern	concern	NOUN
njb-40	24	21	in	in	ADP
njb-40	24	22	case	case	NOUN
njb-40	24	23	of	of	ADP
njb-40	24	24	men	man	NOUN
njb-40	24	25	of	of	ADP
njb-40	24	26	reproductive	reproductive	ADJ
njb-40	24	27	age	age	NOUN
njb-40	24	28	having	have	VERB
njb-40	24	29	tumors	tumor	NOUN
njb-40	24	30	with	with	ADP
njb-40	24	31	high	high	ADJ
njb-40	24	32	cure	cure	NOUN
njb-40	24	33	rates	rate	NOUN
njb-40	24	34	[	[	PUNCT
njb-40	24	35	6	6	NUM
njb-40	24	36	]	]	PUNCT
njb-40	24	37	.	.	PUNCT
njb-40	25	1	thus	thus	ADV
njb-40	25	2	it	it	PRON
njb-40	25	3	seems	seem	VERB
njb-40	25	4	important	important	ADJ
njb-40	25	5	to	to	PART
njb-40	25	6	assess	assess	VERB
njb-40	25	7	the	the	DET
njb-40	25	8	effects	effect	NOUN
njb-40	25	9	of	of	ADP
njb-40	25	10	doxorubicin	doxorubicin	PROPN
njb-40	25	11	on	on	ADP
njb-40	25	12	various	various	ADJ
njb-40	25	13	components	component	NOUN
njb-40	25	14	of	of	ADP
njb-40	25	15	male	male	ADJ
njb-40	25	16	reproductive	reproductive	ADJ
njb-40	25	17	system	system	NOUN
njb-40	25	18	and	and	CCONJ
njb-40	25	19	particularly	particularly	ADV
njb-40	25	20	in	in	ADP
njb-40	25	21	testis	testis	NOUN
njb-40	25	22	where	where	SCONJ
njb-40	25	23	sperm	sperm	NOUN
njb-40	25	24	production	production	NOUN
njb-40	25	25	takes	take	VERB
njb-40	25	26	place	place	NOUN
njb-40	25	27	.	.	PUNCT
njb-40	26	1	different	different	ADJ
njb-40	26	2	studies	study	NOUN
njb-40	26	3	have	have	AUX
njb-40	26	4	been	be	AUX
njb-40	26	5	carried	carry	VERB
njb-40	26	6	out	out	ADP
njb-40	26	7	to	to	PART
njb-40	26	8	investigate	investigate	VERB
njb-40	26	9	the	the	DET
njb-40	26	10	effects	effect	NOUN
njb-40	26	11	of	of	ADP
njb-40	26	12	doxorubicin	doxorubicin	PROPN
njb-40	26	13	on	on	ADP
njb-40	26	14	testis	testis	PROPN
njb-40	26	15	,	,	PUNCT
njb-40	26	16	however	however	ADV
njb-40	26	17	there	there	PRON
njb-40	26	18	are	be	VERB
njb-40	26	19	only	only	ADV
njb-40	26	20	few	few	ADJ
njb-40	26	21	studies	study	NOUN
njb-40	26	22	utilizing	utilize	VERB
njb-40	26	23	stereological	stereological	ADJ
njb-40	26	24	tool	tool	NOUN
njb-40	26	25	to	to	PART
njb-40	26	26	elucidate	elucidate	VERB
njb-40	26	27	histomophometric	histomophometric	ADJ
njb-40	26	28	nepal	nepal	ADJ
njb-40	26	29	journal	journal	NOUN
njb-40	26	30	of	of	ADP
njb-40	26	31	biotechnology	biotechnology	NOUN
njb-40	26	32	.	.	PUNCT
njb-40	27	1	d	d	X
njb-40	27	2	e	e	PROPN
njb-40	27	3	c	c	PROPN
njb-40	27	4	.	.	PUNCT
njb-40	28	1	2	2	NUM
njb-40	28	2	0	0	NUM
njb-40	28	3	1	1	NUM
njb-40	28	4	5	5	NUM
njb-40	28	5	vol	vol	NOUN
njb-40	28	6	.	.	PUNCT
njb-40	29	1	3	3	NUM
njb-40	29	2	,	,	PUNCT
njb-40	29	3	no	no	INTJ
njb-40	29	4	.	.	PUNCT
njb-40	30	1	1:10	1:10	NUM
njb-40	30	2	-	-	SYM
njb-40	30	3	14	14	NUM
njb-40	30	4	sah	sah	PROPN
njb-40	30	5	et	et	PROPN
njb-40	30	6	al	al	PROPN
njb-40	30	7	.	.	PUNCT
njb-40	31	1	©	©	PROPN
njb-40	31	2	njb	njb	PROPN
njb-40	31	3	,	,	PUNCT
njb-40	31	4	biotechnology	biotechnology	NOUN
njb-40	31	5	society	society	NOUN
njb-40	31	6	of	of	ADP
njb-40	31	7	nepal	nepal	ADJ
njb-40	31	8	11	11	NUM
njb-40	31	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	ADJ
njb-40	31	10	evidences	evidence	NOUN
njb-40	31	11	of	of	ADP
njb-40	31	12	doxorubicin	doxorubicin	PROPN
njb-40	31	13	mediated	mediate	VERB
njb-40	31	14	derangement	derangement	NOUN
njb-40	31	15	of	of	ADP
njb-40	31	16	the	the	DET
njb-40	31	17	testis	testis	NOUN
njb-40	31	18	and	and	CCONJ
njb-40	31	19	evaluate	evaluate	VERB
njb-40	31	20	midterm	midterm	NOUN
njb-40	31	21	and	and	CCONJ
njb-40	31	22	long	long	ADJ
njb-40	31	23	term	term	NOUN
njb-40	31	24	effects	effect	NOUN
njb-40	31	25	of	of	ADP
njb-40	31	26	doxorubicin	doxorubicin	PROPN
njb-40	31	27	[	[	PUNCT
njb-40	31	28	7	7	NUM
njb-40	31	29	]	]	PUNCT
njb-40	31	30	.	.	PUNCT
njb-40	32	1	considering	consider	VERB
njb-40	32	2	this	this	PRON
njb-40	32	3	we	we	PRON
njb-40	32	4	conducted	conduct	VERB
njb-40	32	5	the	the	DET
njb-40	32	6	present	present	ADJ
njb-40	32	7	study	study	NOUN
njb-40	32	8	among	among	ADP
njb-40	32	9	albino	albino	NOUN
njb-40	32	10	rats	rat	NOUN
njb-40	32	11	to	to	PART
njb-40	32	12	find	find	VERB
njb-40	32	13	short	short	ADJ
njb-40	32	14	,	,	PUNCT
njb-40	32	15	mid	mid	ADJ
njb-40	32	16	and	and	CCONJ
njb-40	32	17	long	long	ADJ
njb-40	32	18	term	term	NOUN
njb-40	32	19	effects	effect	NOUN
njb-40	32	20	of	of	ADP
njb-40	32	21	doxorubicin	doxorubicin	PROPN
njb-40	32	22	on	on	ADP
njb-40	32	23	histomorphometric	histomorphometric	ADJ
njb-40	32	24	characters	character	NOUN
njb-40	32	25	of	of	ADP
njb-40	32	26	testis	testis	NOUN
njb-40	32	27	as	as	SCONJ
njb-40	32	28	compared	compare	VERB
njb-40	32	29	to	to	ADP
njb-40	32	30	controls	control	NOUN
njb-40	32	31	.	.	PUNCT
njb-40	33	1	methods	method	NOUN
njb-40	33	2	the	the	DET
njb-40	33	3	study	study	NOUN
njb-40	33	4	was	be	AUX
njb-40	33	5	conducted	conduct	VERB
njb-40	33	6	at	at	ADP
njb-40	33	7	the	the	DET
njb-40	33	8	department	department	NOUN
njb-40	33	9	of	of	ADP
njb-40	33	10	anatomy	anatomy	NOUN
njb-40	33	11	of	of	ADP
njb-40	33	12	b	b	PROPN
njb-40	33	13	p	p	PROPN
njb-40	33	14	koirala	koirala	PROPN
njb-40	33	15	institute	institute	PROPN
njb-40	33	16	of	of	ADP
njb-40	33	17	health	health	PROPN
njb-40	33	18	sciences	sciences	PROPN
njb-40	33	19	,	,	PUNCT
njb-40	33	20	dharan	dharan	PROPN
njb-40	33	21	,	,	PUNCT
njb-40	33	22	nepal	nepal	ADJ
njb-40	33	23	to	to	PART
njb-40	33	24	find	find	VERB
njb-40	33	25	the	the	DET
njb-40	33	26	short	short	ADJ
njb-40	33	27	,	,	PUNCT
njb-40	33	28	mid	mid	ADJ
njb-40	33	29	and	and	CCONJ
njb-40	33	30	long	long	ADJ
njb-40	33	31	term	term	NOUN
njb-40	33	32	effects	effect	NOUN
njb-40	33	33	of	of	ADP
njb-40	33	34	doxorubicin	doxorubicin	PROPN
njb-40	33	35	on	on	ADP
njb-40	33	36	testis	testis	NOUN
njb-40	33	37	of	of	ADP
njb-40	33	38	albino	albino	ADJ
njb-40	33	39	rat	rat	NOUN
njb-40	33	40	as	as	SCONJ
njb-40	33	41	compared	compare	VERB
njb-40	33	42	to	to	ADP
njb-40	33	43	controls	control	NOUN
njb-40	33	44	.	.	PUNCT
njb-40	34	1	sixty	sixty	NUM
njb-40	34	2	healthy	healthy	ADJ
njb-40	34	3	albino	albino	NOUN
njb-40	34	4	rats	rat	NOUN
njb-40	34	5	aged	age	VERB
njb-40	34	6	6	6	NUM
njb-40	34	7	-	-	SYM
njb-40	34	8	8	8	NUM
njb-40	34	9	weeks	week	NOUN
njb-40	34	10	and	and	CCONJ
njb-40	34	11	weighing	weigh	VERB
njb-40	34	12	150	150	NUM
njb-40	34	13	-	-	SYM
njb-40	34	14	200	200	NUM
njb-40	34	15	gm	gm	NOUN
njb-40	34	16	were	be	AUX
njb-40	34	17	obtained	obtain	VERB
njb-40	34	18	from	from	ADP
njb-40	34	19	the	the	DET
njb-40	34	20	animal	animal	NOUN
njb-40	34	21	house	house	NOUN
njb-40	34	22	of	of	ADP
njb-40	34	23	anatomy	anatomy	PROPN
njb-40	34	24	department	department	PROPN
njb-40	34	25	and	and	CCONJ
njb-40	34	26	used	use	VERB
njb-40	34	27	in	in	ADP
njb-40	34	28	study	study	NOUN
njb-40	34	29	.	.	PUNCT
njb-40	35	1	they	they	PRON
njb-40	35	2	were	be	AUX
njb-40	35	3	housed	house	VERB
njb-40	35	4	in	in	ADP
njb-40	35	5	well	well	ADV
njb-40	35	6	ventilated	ventilate	VERB
njb-40	35	7	room	room	NOUN
njb-40	35	8	at	at	ADP
njb-40	35	9	controlled	control	VERB
njb-40	35	10	ambient	ambient	NOUN
njb-40	35	11	temperature	temperature	NOUN
njb-40	35	12	(	(	PUNCT
njb-40	35	13	25±5	25±5	NUM
njb-40	35	14	0c	0c	NUM
njb-40	35	15	)	)	PUNCT
njb-40	35	16	with	with	ADP
njb-40	35	17	a	a	DET
njb-40	35	18	12	12	NUM
njb-40	35	19	hour	hour	NOUN
njb-40	35	20	alternating	alternate	VERB
njb-40	35	21	light	light	ADJ
njb-40	35	22	-	-	PUNCT
njb-40	35	23	dark	dark	NOUN
njb-40	35	24	cycle	cycle	NOUN
njb-40	35	25	and	and	CCONJ
njb-40	35	26	provided	provide	VERB
njb-40	35	27	standard	standard	ADJ
njb-40	35	28	rodent	rodent	NOUN
njb-40	35	29	diet	diet	NOUN
njb-40	35	30	and	and	CCONJ
njb-40	35	31	water	water	NOUN
njb-40	35	32	throughout	throughout	ADP
njb-40	35	33	the	the	DET
njb-40	35	34	study	study	NOUN
njb-40	35	35	period	period	NOUN
njb-40	35	36	.	.	PUNCT
njb-40	36	1	the	the	DET
njb-40	36	2	experimental	experimental	ADJ
njb-40	36	3	work	work	NOUN
njb-40	36	4	was	be	AUX
njb-40	36	5	carried	carry	VERB
njb-40	36	6	out	out	ADP
njb-40	36	7	as	as	ADP
njb-40	36	8	per	per	ADP
njb-40	36	9	research	research	NOUN
njb-40	36	10	and	and	CCONJ
njb-40	36	11	ethical	ethical	ADJ
njb-40	36	12	guidelines	guideline	NOUN
njb-40	36	13	of	of	ADP
njb-40	36	14	nepal	nepal	ADJ
njb-40	36	15	health	health	PROPN
njb-40	36	16	research	research	PROPN
njb-40	36	17	council	council	PROPN
njb-40	36	18	(	(	PUNCT
njb-40	36	19	nhrc	nhrc	PROPN
njb-40	36	20	)	)	PUNCT
njb-40	36	21	for	for	ADP
njb-40	36	22	the	the	DET
njb-40	36	23	care	care	NOUN
njb-40	36	24	and	and	CCONJ
njb-40	36	25	use	use	NOUN
njb-40	36	26	of	of	ADP
njb-40	36	27	animals	animal	NOUN
njb-40	36	28	in	in	ADP
njb-40	36	29	health	health	NOUN
njb-40	36	30	research	research	NOUN
njb-40	36	31	in	in	ADP
njb-40	36	32	nepal	nepal	ADJ
njb-40	36	33	and	and	CCONJ
njb-40	36	34	the	the	DET
njb-40	36	35	research	research	NOUN
njb-40	36	36	protocol	protocol	NOUN
njb-40	36	37	was	be	AUX
njb-40	36	38	approved	approve	VERB
njb-40	36	39	by	by	ADP
njb-40	36	40	the	the	DET
njb-40	36	41	institute	institute	PROPN
njb-40	36	42	review	review	PROPN
njb-40	36	43	board	board	PROPN
njb-40	36	44	of	of	ADP
njb-40	36	45	b	b	PROPN
njb-40	36	46	p	p	PROPN
njb-40	36	47	koirala	koirala	PROPN
njb-40	36	48	institute	institute	PROPN
njb-40	36	49	of	of	ADP
njb-40	36	50	health	health	PROPN
njb-40	36	51	sciences	science	NOUN
njb-40	36	52	.	.	PUNCT
njb-40	37	1	the	the	DET
njb-40	37	2	rats	rat	NOUN
njb-40	37	3	were	be	AUX
njb-40	37	4	randomly	randomly	ADV
njb-40	37	5	divided	divide	VERB
njb-40	37	6	into	into	ADP
njb-40	37	7	3	3	NUM
njb-40	37	8	groups	group	NOUN
njb-40	37	9	of	of	ADP
njb-40	37	10	experimental	experimental	ADJ
njb-40	37	11	(	(	PUNCT
njb-40	37	12	each	each	DET
njb-40	37	13	group	group	NOUN
njb-40	37	14	containing	contain	VERB
njb-40	37	15	10	10	NUM
njb-40	37	16	rats	rat	NOUN
njb-40	37	17	)	)	PUNCT
njb-40	37	18	and	and	CCONJ
njb-40	37	19	3	3	NUM
njb-40	37	20	groups	group	NOUN
njb-40	37	21	of	of	ADP
njb-40	37	22	control	control	NOUN
njb-40	37	23	(	(	PUNCT
njb-40	37	24	each	each	DET
njb-40	37	25	group	group	NOUN
njb-40	37	26	containing	contain	VERB
njb-40	37	27	10	10	NUM
njb-40	37	28	rats	rat	NOUN
njb-40	37	29	)	)	PUNCT
njb-40	37	30	,	,	PUNCT
njb-40	37	31	such	such	ADJ
njb-40	37	32	that	that	DET
njb-40	37	33	weight	weight	NOUN
njb-40	37	34	do	do	AUX
njb-40	37	35	not	not	PART
njb-40	37	36	vary	vary	VERB
njb-40	37	37	by	by	ADP
njb-40	37	38	more	more	ADJ
njb-40	37	39	than	than	ADP
njb-40	37	40	10	10	NUM
njb-40	37	41	%	%	NOUN
njb-40	37	42	of	of	ADP
njb-40	37	43	average	average	ADJ
njb-40	37	44	weight	weight	NOUN
njb-40	37	45	of	of	ADP
njb-40	37	46	study	study	NOUN
njb-40	37	47	population	population	NOUN
njb-40	37	48	.	.	PUNCT
njb-40	38	1	the	the	DET
njb-40	38	2	experimental	experimental	ADJ
njb-40	38	3	groups	group	NOUN
njb-40	38	4	were	be	AUX
njb-40	38	5	given	give	VERB
njb-40	38	6	a	a	DET
njb-40	38	7	single	single	ADJ
njb-40	38	8	dose	dose	NOUN
njb-40	38	9	of	of	ADP
njb-40	38	10	doxorubicin	doxorubicin	PROPN
njb-40	38	11	i.e.	i.e.	X
njb-40	38	12	10	10	NUM
njb-40	38	13	mg	mg	PROPN
njb-40	38	14	/	/	SYM
njb-40	38	15	kg	kg	NOUN
njb-40	38	16	body	body	NOUN
njb-40	38	17	weight	weight	NOUN
njb-40	38	18	intraperitoneally	intraperitoneally	ADV
njb-40	38	19	and	and	CCONJ
njb-40	38	20	sacrificed	sacrifice	VERB
njb-40	38	21	after	after	ADP
njb-40	38	22	3	3	NUM
njb-40	38	23	different	different	ADJ
njb-40	38	24	duration	duration	NOUN
njb-40	38	25	for	for	ADP
njb-40	38	26	each	each	DET
njb-40	38	27	group	group	NOUN
njb-40	38	28	.	.	PUNCT
njb-40	39	1	group	group	NOUN
njb-40	39	2	1	1	NUM
njb-40	39	3	animals	animal	NOUN
njb-40	39	4	,	,	PUNCT
njb-40	39	5	which	which	PRON
njb-40	39	6	were	be	AUX
njb-40	39	7	investigated	investigate	VERB
njb-40	39	8	for	for	ADP
njb-40	39	9	short	short	ADJ
njb-40	39	10	term	term	NOUN
njb-40	39	11	effect	effect	NOUN
njb-40	39	12	,	,	PUNCT
njb-40	39	13	were	be	AUX
njb-40	39	14	sacrificed	sacrifice	VERB
njb-40	39	15	on	on	ADP
njb-40	39	16	14th	14th	ADJ
njb-40	39	17	day	day	NOUN
njb-40	39	18	(	(	PUNCT
njb-40	39	19	2nd	2nd	ADJ
njb-40	39	20	week	week	NOUN
njb-40	39	21	)	)	PUNCT
njb-40	39	22	.	.	PUNCT
njb-40	40	1	group	group	NOUN
njb-40	40	2	2	2	NUM
njb-40	40	3	animals	animal	NOUN
njb-40	40	4	(	(	PUNCT
njb-40	40	5	studied	study	VERB
njb-40	40	6	for	for	ADP
njb-40	40	7	midterm	midterm	NOUN
njb-40	40	8	effects	effect	NOUN
njb-40	40	9	)	)	PUNCT
njb-40	40	10	were	be	AUX
njb-40	40	11	sacrificed	sacrifice	VERB
njb-40	40	12	on	on	ADP
njb-40	40	13	56th	56th	ADJ
njb-40	40	14	day	day	NOUN
njb-40	40	15	(	(	PUNCT
njb-40	40	16	8th	8th	ADJ
njb-40	40	17	week	week	NOUN
njb-40	40	18	)	)	PUNCT
njb-40	40	19	,	,	PUNCT
njb-40	40	20	and	and	CCONJ
njb-40	40	21	group	group	NOUN
njb-40	40	22	3	3	NUM
njb-40	40	23	animals	animal	NOUN
njb-40	40	24	(	(	PUNCT
njb-40	40	25	studied	study	VERB
njb-40	40	26	for	for	ADP
njb-40	40	27	long	long	ADJ
njb-40	40	28	term	term	NOUN
njb-40	40	29	effects	effect	NOUN
njb-40	40	30	)	)	PUNCT
njb-40	40	31	on	on	ADP
njb-40	40	32	112th	112th	PROPN
njb-40	40	33	day	day	NOUN
njb-40	40	34	(	(	PUNCT
njb-40	40	35	16th	16th	ADJ
njb-40	40	36	week	week	NOUN
njb-40	40	37	)	)	PUNCT
njb-40	40	38	.	.	PUNCT
njb-40	41	1	all	all	DET
njb-40	41	2	rats	rat	NOUN
njb-40	41	3	under	under	ADP
njb-40	41	4	3	3	NUM
njb-40	41	5	control	control	NOUN
njb-40	41	6	groups	group	NOUN
njb-40	41	7	(	(	PUNCT
njb-40	41	8	control	control	NOUN
njb-40	41	9	1	1	NUM
njb-40	41	10	,	,	PUNCT
njb-40	41	11	control	control	NOUN
njb-40	41	12	2	2	NUM
njb-40	41	13	and	and	CCONJ
njb-40	41	14	control	control	NOUN
njb-40	41	15	3	3	NUM
njb-40	41	16	)	)	PUNCT
njb-40	41	17	were	be	AUX
njb-40	41	18	given	give	VERB
njb-40	41	19	a	a	DET
njb-40	41	20	single	single	ADJ
njb-40	41	21	intra	intra	ADJ
njb-40	41	22	-	-	ADJ
njb-40	41	23	peritoneal	peritoneal	ADJ
njb-40	41	24	dose	dose	NOUN
njb-40	41	25	of	of	ADP
njb-40	41	26	2.5	2.5	NUM
njb-40	41	27	ml	ml	PROPN
njb-40	41	28	/	/	SYM
njb-40	41	29	kg	kg	NOUN
njb-40	41	30	body	body	NOUN
njb-40	41	31	weight	weight	NOUN
njb-40	41	32	normal	normal	ADJ
njb-40	41	33	saline	saline	NOUN
njb-40	41	34	and	and	CCONJ
njb-40	41	35	sacrificed	sacrifice	VERB
njb-40	41	36	with	with	ADP
njb-40	41	37	their	their	PRON
njb-40	41	38	respective	respective	ADJ
njb-40	41	39	experimental	experimental	ADJ
njb-40	41	40	groups	group	NOUN
njb-40	41	41	(	(	PUNCT
njb-40	41	42	at	at	ADP
njb-40	41	43	second	second	ADJ
njb-40	41	44	,	,	PUNCT
njb-40	41	45	eighth	eighth	ADJ
njb-40	41	46	and	and	CCONJ
njb-40	41	47	sixteen	sixteen	NUM
njb-40	41	48	weeks	week	NOUN
njb-40	41	49	respectively	respectively	ADV
njb-40	41	50	)	)	PUNCT
njb-40	41	51	.	.	PUNCT
njb-40	42	1	comparison	comparison	NOUN
njb-40	42	2	was	be	AUX
njb-40	42	3	done	do	VERB
njb-40	42	4	among	among	ADP
njb-40	42	5	3	3	NUM
njb-40	42	6	groups	group	NOUN
njb-40	42	7	of	of	ADP
njb-40	42	8	experimental	experimental	ADJ
njb-40	42	9	rats	rat	NOUN
njb-40	42	10	in	in	ADP
njb-40	42	11	terms	term	NOUN
njb-40	42	12	of	of	ADP
njb-40	42	13	effect	effect	NOUN
njb-40	42	14	of	of	ADP
njb-40	42	15	doxorubicin	doxorubicin	PROPN
njb-40	42	16	,	,	PUNCT
njb-40	42	17	and	and	CCONJ
njb-40	42	18	as	as	ADV
njb-40	42	19	well	well	ADV
njb-40	42	20	as	as	ADP
njb-40	42	21	between	between	ADP
njb-40	42	22	each	each	DET
njb-40	42	23	matched	match	VERB
njb-40	42	24	experimental	experimental	ADJ
njb-40	42	25	and	and	CCONJ
njb-40	42	26	control	control	NOUN
njb-40	42	27	group	group	NOUN
njb-40	42	28	.	.	PUNCT
njb-40	43	1	all	all	DET
njb-40	43	2	rats	rat	NOUN
njb-40	43	3	were	be	AUX
njb-40	43	4	weighed	weigh	VERB
njb-40	43	5	at	at	ADP
njb-40	43	6	the	the	DET
njb-40	43	7	time	time	NOUN
njb-40	43	8	of	of	ADP
njb-40	43	9	euthanasia	euthanasia	NOUN
njb-40	43	10	.	.	PUNCT
njb-40	44	1	animals	animal	NOUN
njb-40	44	2	were	be	AUX
njb-40	44	3	anesthetized	anesthetize	VERB
njb-40	44	4	with	with	ADP
njb-40	44	5	ether	ether	NOUN
njb-40	44	6	soaked	soak	VERB
njb-40	44	7	in	in	ADP
njb-40	44	8	cotton	cotton	NOUN
njb-40	44	9	and	and	CCONJ
njb-40	44	10	their	their	PRON
njb-40	44	11	testes	testis	NOUN
njb-40	44	12	were	be	AUX
njb-40	44	13	fixed	fix	VERB
njb-40	44	14	by	by	ADP
njb-40	44	15	in	in	ADP
njb-40	44	16	vivo	vivo	NOUN
njb-40	44	17	perfusion	perfusion	NOUN
njb-40	44	18	technique	technique	NOUN
njb-40	44	19	as	as	SCONJ
njb-40	44	20	mentioned	mention	VERB
njb-40	44	21	below	below	ADV
njb-40	44	22	.	.	PUNCT
njb-40	45	1	rats	rat	NOUN
njb-40	45	2	were	be	AUX
njb-40	45	3	kept	keep	VERB
njb-40	45	4	on	on	ADP
njb-40	45	5	the	the	DET
njb-40	45	6	dissecting	dissect	VERB
njb-40	45	7	tray	tray	NOUN
njb-40	45	8	with	with	ADP
njb-40	45	9	their	their	PRON
njb-40	45	10	ventral	ventral	ADJ
njb-40	45	11	surface	surface	NOUN
njb-40	45	12	facing	face	VERB
njb-40	45	13	upward	upward	ADV
njb-40	45	14	and	and	CCONJ
njb-40	45	15	all	all	DET
njb-40	45	16	four	four	NUM
njb-40	45	17	limbs	limb	NOUN
njb-40	45	18	pinned	pin	VERB
njb-40	45	19	.	.	PUNCT
njb-40	46	1	the	the	DET
njb-40	46	2	abdomen	abdomen	NOUN
njb-40	46	3	was	be	AUX
njb-40	46	4	opened	open	VERB
njb-40	46	5	to	to	PART
njb-40	46	6	expose	expose	VERB
njb-40	46	7	the	the	DET
njb-40	46	8	abdominal	abdominal	ADJ
njb-40	46	9	aorta	aorta	NOUN
njb-40	46	10	and	and	CCONJ
njb-40	46	11	inferior	inferior	ADJ
njb-40	46	12	vena	vena	NOUN
njb-40	46	13	cava	cava	NOUN
njb-40	46	14	.	.	PUNCT
njb-40	47	1	a	a	DET
njb-40	47	2	18	18	NUM
njb-40	47	3	guage	guage	NOUN
njb-40	47	4	needle	needle	NOUN
njb-40	47	5	was	be	AUX
njb-40	47	6	inserted	insert	VERB
njb-40	47	7	on	on	ADP
njb-40	47	8	the	the	DET
njb-40	47	9	abdominal	abdominal	ADJ
njb-40	47	10	aorta	aorta	NOUN
njb-40	47	11	and	and	CCONJ
njb-40	47	12	tied	tie	VERB
njb-40	47	13	with	with	ADP
njb-40	47	14	thread	thread	NOUN
njb-40	47	15	to	to	PART
njb-40	47	16	keep	keep	VERB
njb-40	47	17	it	it	PRON
njb-40	47	18	in	in	ADP
njb-40	47	19	constant	constant	ADJ
njb-40	47	20	position	position	NOUN
njb-40	47	21	.	.	PUNCT
njb-40	48	1	the	the	DET
njb-40	48	2	needle	needle	NOUN
njb-40	48	3	was	be	AUX
njb-40	48	4	attached	attach	VERB
njb-40	48	5	to	to	ADP
njb-40	48	6	clean	clean	ADJ
njb-40	48	7	flask	flask	NOUN
njb-40	48	8	tube	tube	NOUN
njb-40	48	9	,	,	PUNCT
njb-40	48	10	connected	connect	VERB
njb-40	48	11	with	with	ADP
njb-40	48	12	two	two	NUM
njb-40	48	13	bottles	bottle	NOUN
njb-40	48	14	containing	contain	VERB
njb-40	48	15	bouin	bouin	NOUN
njb-40	48	16	’s	’s	PART
njb-40	48	17	fluid	fluid	ADJ
njb-40	48	18	and	and	CCONJ
njb-40	48	19	physiological	physiological	ADJ
njb-40	48	20	saline	saline	NOUN
njb-40	48	21	separately	separately	ADV
njb-40	48	22	.	.	PUNCT
njb-40	49	1	then	then	ADV
njb-40	49	2	the	the	DET
njb-40	49	3	chest	chest	NOUN
njb-40	49	4	was	be	AUX
njb-40	49	5	opened	open	VERB
njb-40	49	6	and	and	CCONJ
njb-40	49	7	the	the	DET
njb-40	49	8	right	right	ADJ
njb-40	49	9	atrium	atrium	NOUN
njb-40	49	10	was	be	AUX
njb-40	49	11	nicked	nick	VERB
njb-40	49	12	by	by	ADP
njb-40	49	13	a	a	DET
njb-40	49	14	scissor	scissor	NOUN
njb-40	49	15	or	or	CCONJ
njb-40	49	16	knife	knife	NOUN
njb-40	49	17	(	(	PUNCT
njb-40	49	18	scalpel	scalpel	NOUN
njb-40	49	19	)	)	PUNCT
njb-40	49	20	to	to	PART
njb-40	49	21	permit	permit	VERB
njb-40	49	22	the	the	DET
njb-40	49	23	drainage	drainage	NOUN
njb-40	49	24	of	of	ADP
njb-40	49	25	blood	blood	NOUN
njb-40	49	26	.	.	PUNCT
njb-40	50	1	thereafter	thereafter	ADV
njb-40	50	2	,	,	PUNCT
njb-40	50	3	the	the	DET
njb-40	50	4	physiological	physiological	ADJ
njb-40	50	5	saline	saline	NOUN
njb-40	50	6	was	be	AUX
njb-40	50	7	perfused	perfuse	VERB
njb-40	50	8	to	to	PART
njb-40	50	9	flush	flush	VERB
njb-40	50	10	out	out	ADP
njb-40	50	11	the	the	DET
njb-40	50	12	blood	blood	NOUN
njb-40	50	13	.	.	PUNCT
njb-40	51	1	the	the	DET
njb-40	51	2	fixative	fixative	ADJ
njb-40	51	3	bouin	bouin	NOUN
njb-40	51	4	’s	’s	PART
njb-40	51	5	fluid	fluid	NOUN
njb-40	51	6	was	be	AUX
njb-40	51	7	then	then	ADV
njb-40	51	8	transfused	transfuse	VERB
njb-40	51	9	with	with	ADP
njb-40	51	10	the	the	DET
njb-40	51	11	help	help	NOUN
njb-40	51	12	of	of	ADP
njb-40	51	13	three	three	NUM
njb-40	51	14	ways	way	NOUN
njb-40	51	15	stopcock	stopcock	VERB
njb-40	51	16	.	.	PUNCT
njb-40	52	1	approximately	approximately	ADV
njb-40	52	2	200	200	NUM
njb-40	52	3	ml	ml	NOUN
njb-40	52	4	of	of	ADP
njb-40	52	5	each	each	DET
njb-40	52	6	fluid	fluid	NOUN
njb-40	52	7	was	be	AUX
njb-40	52	8	perfused	perfuse	VERB
njb-40	52	9	.	.	PUNCT
njb-40	53	1	perfusion	perfusion	PROPN
njb-40	53	2	was	be	AUX
njb-40	53	3	stopped	stop	VERB
njb-40	53	4	when	when	SCONJ
njb-40	53	5	clear	clear	ADJ
njb-40	53	6	fixative	fixative	ADJ
njb-40	53	7	drops	drop	NOUN
njb-40	53	8	started	start	VERB
njb-40	53	9	oozing	ooze	VERB
njb-40	53	10	out	out	ADP
njb-40	53	11	from	from	ADP
njb-40	53	12	the	the	DET
njb-40	53	13	snout	snout	NOUN
njb-40	53	14	of	of	ADP
njb-40	53	15	the	the	DET
njb-40	53	16	animal	animal	NOUN
njb-40	53	17	.	.	PUNCT
njb-40	54	1	after	after	ADP
njb-40	54	2	completion	completion	NOUN
njb-40	54	3	of	of	ADP
njb-40	54	4	perfusion	perfusion	NOUN
njb-40	54	5	,	,	PUNCT
njb-40	54	6	the	the	DET
njb-40	54	7	testes	testis	NOUN
njb-40	54	8	were	be	AUX
njb-40	54	9	isolated	isolate	VERB
njb-40	54	10	from	from	ADP
njb-40	54	11	the	the	DET
njb-40	54	12	scrotum	scrotum	NOUN
njb-40	54	13	with	with	ADP
njb-40	54	14	the	the	DET
njb-40	54	15	help	help	NOUN
njb-40	54	16	of	of	ADP
njb-40	54	17	scalpel	scalpel	NOUN
njb-40	54	18	and	and	CCONJ
njb-40	54	19	forceps	forceps	NOUN
njb-40	54	20	and	and	CCONJ
njb-40	54	21	weight	weight	NOUN
njb-40	54	22	was	be	AUX
njb-40	54	23	measured	measure	VERB
njb-40	54	24	followed	follow	VERB
njb-40	54	25	by	by	ADP
njb-40	54	26	volume	volume	NOUN
njb-40	54	27	measurement	measurement	NOUN
njb-40	54	28	by	by	ADP
njb-40	54	29	the	the	DET
njb-40	54	30	application	application	NOUN
njb-40	54	31	of	of	ADP
njb-40	54	32	water	water	NOUN
njb-40	54	33	displacement	displacement	NOUN
njb-40	54	34	method	method	NOUN
njb-40	54	35	and	and	CCONJ
njb-40	54	36	post	post	NOUN
njb-40	54	37	fixed	fix	VERB
njb-40	54	38	for	for	ADP
njb-40	54	39	24	24	NUM
njb-40	54	40	hours	hour	NOUN
njb-40	54	41	by	by	ADP
njb-40	54	42	the	the	DET
njb-40	54	43	same	same	ADJ
njb-40	54	44	fixative	fixative	ADJ
njb-40	54	45	.	.	PUNCT
njb-40	55	1	after	after	ADP
njb-40	55	2	18	18	NUM
njb-40	55	3	hour	hour	NOUN
njb-40	55	4	fixation	fixation	NOUN
njb-40	55	5	in	in	ADP
njb-40	55	6	bouin	bouin	PROPN
njb-40	55	7	’s	’s	PART
njb-40	55	8	fluid	fluid	NOUN
njb-40	55	9	,	,	PUNCT
njb-40	55	10	the	the	DET
njb-40	55	11	tissue	tissue	NOUN
njb-40	55	12	was	be	AUX
njb-40	55	13	processed	process	VERB
njb-40	55	14	and	and	CCONJ
njb-40	55	15	histological	histological	ADJ
njb-40	55	16	slides	slide	NOUN
njb-40	55	17	were	be	AUX
njb-40	55	18	prepared	prepare	VERB
njb-40	55	19	from	from	ADP
njb-40	55	20	vertical	vertical	ADJ
njb-40	55	21	sections	section	NOUN
njb-40	55	22	from	from	ADP
njb-40	55	23	the	the	DET
njb-40	55	24	polar	polar	ADJ
njb-40	55	25	and	and	CCONJ
njb-40	55	26	the	the	DET
njb-40	55	27	equatorial	equatorial	ADJ
njb-40	55	28	regions	region	NOUN
njb-40	55	29	of	of	ADP
njb-40	55	30	each	each	DET
njb-40	55	31	testis	testis	NOUN
njb-40	55	32	.	.	PUNCT
njb-40	56	1	micrometer	micrometer	NOUN
njb-40	56	2	was	be	AUX
njb-40	56	3	used	use	VERB
njb-40	56	4	for	for	ADP
njb-40	56	5	quantitative	quantitative	ADJ
njb-40	56	6	measurement	measurement	NOUN
njb-40	56	7	of	of	ADP
njb-40	56	8	parameter	parameter	NOUN
njb-40	56	9	;	;	PUNCT
njb-40	56	10	diameter	diameter	NOUN
njb-40	56	11	of	of	ADP
njb-40	56	12	seminiferous	seminiferous	ADJ
njb-40	56	13	tubules	tubule	NOUN
njb-40	56	14	,	,	PUNCT
njb-40	56	15	and	and	CCONJ
njb-40	56	16	interstitial	interstitial	ADJ
njb-40	56	17	spaces	space	NOUN
njb-40	56	18	,	,	PUNCT
njb-40	56	19	germ	germ	NOUN
njb-40	56	20	cells	cell	NOUN
njb-40	56	21	,	,	PUNCT
njb-40	56	22	sertoli	sertoli	PROPN
njb-40	56	23	cells	cell	NOUN
njb-40	56	24	and	and	CCONJ
njb-40	56	25	leydig	leydig	PROPN
njb-40	56	26	cells	cell	NOUN
njb-40	56	27	were	be	AUX
njb-40	56	28	observed	observe	VERB
njb-40	56	29	qualitatively	qualitatively	ADV
njb-40	56	30	in	in	ADP
njb-40	56	31	histological	histological	ADJ
njb-40	56	32	slides	slide	NOUN
njb-40	56	33	.	.	PUNCT
njb-40	57	1	diameter	diameter	PROPN
njb-40	57	2	(	(	PUNCT
njb-40	57	3	d	d	NOUN
njb-40	57	4	)	)	PUNCT
njb-40	57	5	of	of	ADP
njb-40	57	6	each	each	DET
njb-40	57	7	seminiferous	seminiferous	ADJ
njb-40	57	8	tubule	tubule	NOUN
njb-40	57	9	was	be	AUX
njb-40	57	10	measured	measure	VERB
njb-40	57	11	by	by	ADP
njb-40	57	12	two	two	NUM
njb-40	57	13	directions	direction	NOUN
njb-40	57	14	and	and	CCONJ
njb-40	57	15	mean	mean	VERB
njb-40	57	16	of	of	ADP
njb-40	57	17	two	two	NUM
njb-40	57	18	was	be	AUX
njb-40	57	19	taken	take	VERB
njb-40	57	20	as	as	ADP
njb-40	57	21	a	a	DET
njb-40	57	22	diameter	diameter	NOUN
njb-40	57	23	of	of	ADP
njb-40	57	24	that	that	DET
njb-40	57	25	seminiferous	seminiferous	ADJ
njb-40	57	26	tubule	tubule	NOUN
njb-40	57	27	.	.	PUNCT
njb-40	58	1	the	the	DET
njb-40	58	2	cross	cross	ADJ
njb-40	58	3	-	-	ADJ
njb-40	58	4	sectional	sectional	ADJ
njb-40	58	5	area	area	NOUN
njb-40	58	6	of	of	ADP
njb-40	58	7	the	the	DET
njb-40	58	8	seminiferous	seminiferous	ADJ
njb-40	58	9	tubules	tubule	NOUN
njb-40	58	10	were	be	AUX
njb-40	58	11	determined	determine	VERB
njb-40	58	12	by	by	ADP
njb-40	58	13	formula	formula	NOUN
njb-40	58	14	;	;	PUNCT
njb-40	58	15	area	area	NOUN
njb-40	58	16	(	(	PUNCT
njb-40	58	17	a)=πd2/4	a)=πd2/4	PROPN
njb-40	58	18	.	.	PROPN
njb-40	58	19	two	two	NUM
njb-40	58	20	slides	slide	NOUN
njb-40	58	21	per	per	ADP
njb-40	58	22	rat	rat	NOUN
njb-40	58	23	were	be	AUX
njb-40	58	24	observed	observe	VERB
njb-40	58	25	for	for	ADP
njb-40	58	26	both	both	CCONJ
njb-40	58	27	control	control	NOUN
njb-40	58	28	and	and	CCONJ
njb-40	58	29	experimental	experimental	ADJ
njb-40	58	30	groups	group	NOUN
njb-40	58	31	.	.	PUNCT
njb-40	59	1	statistical	statistical	ADJ
njb-40	59	2	analysis	analysis	NOUN
njb-40	59	3	was	be	AUX
njb-40	59	4	done	do	VERB
njb-40	59	5	in	in	ADP
njb-40	59	6	spss	spss	PROPN
njb-40	59	7	version	version	PROPN
njb-40	59	8	19	19	NUM
njb-40	59	9	.	.	PUNCT
njb-40	60	1	all	all	DET
njb-40	60	2	data	datum	NOUN
njb-40	60	3	were	be	AUX
njb-40	60	4	expressed	express	VERB
njb-40	60	5	as	as	ADP
njb-40	60	6	mean	mean	ADJ
njb-40	60	7	±sd	±sd	PROPN
njb-40	60	8	.	.	PUNCT
njb-40	61	1	independent	independent	ADJ
njb-40	61	2	t	t	PROPN
njb-40	61	3	test	test	NOUN
njb-40	61	4	and	and	CCONJ
njb-40	61	5	one	one	NUM
njb-40	61	6	way	way	NOUN
njb-40	61	7	anova	anova	PROPN
njb-40	61	8	was	be	AUX
njb-40	61	9	applied	apply	VERB
njb-40	61	10	to	to	PART
njb-40	61	11	test	test	VERB
njb-40	61	12	for	for	ADP
njb-40	61	13	statistical	statistical	ADJ
njb-40	61	14	significance	significance	NOUN
njb-40	61	15	at	at	ADP
njb-40	61	16	95	95	NUM
njb-40	61	17	%	%	NOUN
njb-40	61	18	confidence	confidence	NOUN
njb-40	61	19	interval	interval	NOUN
njb-40	61	20	.	.	PUNCT
njb-40	62	1	a	a	DET
njb-40	62	2	nepal	nepal	ADJ
njb-40	62	3	journal	journal	NOUN
njb-40	62	4	of	of	ADP
njb-40	62	5	biotechnology	biotechnology	NOUN
njb-40	62	6	.	.	PUNCT
njb-40	63	1	d	d	X
njb-40	63	2	e	e	PROPN
njb-40	63	3	c	c	PROPN
njb-40	63	4	.	.	PUNCT
njb-40	64	1	2	2	NUM
njb-40	64	2	0	0	NUM
njb-40	64	3	1	1	NUM
njb-40	64	4	5	5	NUM
njb-40	64	5	vol	vol	NOUN
njb-40	64	6	.	.	PUNCT
njb-40	65	1	3	3	NUM
njb-40	65	2	,	,	PUNCT
njb-40	65	3	no	no	INTJ
njb-40	65	4	.	.	PUNCT
njb-40	66	1	1:10	1:10	NUM
njb-40	66	2	-	-	SYM
njb-40	66	3	14	14	NUM
njb-40	66	4	sah	sah	PROPN
njb-40	66	5	et	et	PROPN
njb-40	66	6	al	al	PROPN
njb-40	66	7	.	.	PUNCT
njb-40	67	1	©	©	PROPN
njb-40	67	2	njb	njb	PROPN
njb-40	67	3	,	,	PUNCT
njb-40	67	4	biotechnology	biotechnology	NOUN
njb-40	67	5	society	society	NOUN
njb-40	67	6	of	of	ADP
njb-40	67	7	nepal	nepal	ADJ
njb-40	67	8	12	12	NUM
njb-40	67	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	ADJ
njb-40	67	10	value	value	NOUN
njb-40	67	11	of	of	ADP
njb-40	67	12	p<0.05	p<0.05	NOUN
njb-40	67	13	was	be	AUX
njb-40	67	14	considered	consider	VERB
njb-40	67	15	statistically	statistically	ADV
njb-40	67	16	significant	significant	ADJ
njb-40	67	17	.	.	PUNCT
njb-40	68	1	results	result	NOUN
njb-40	68	2	it	it	PRON
njb-40	68	3	was	be	AUX
njb-40	68	4	observed	observe	VERB
njb-40	68	5	that	that	SCONJ
njb-40	68	6	mean	mean	VERB
njb-40	68	7	body	body	NOUN
njb-40	68	8	weight	weight	NOUN
njb-40	68	9	consistently	consistently	ADV
njb-40	68	10	decreased	decrease	VERB
njb-40	68	11	among	among	ADP
njb-40	68	12	the	the	DET
njb-40	68	13	short	short	ADJ
njb-40	68	14	term	term	NOUN
njb-40	68	15	and	and	CCONJ
njb-40	68	16	long	long	ADJ
njb-40	68	17	term	term	NOUN
njb-40	68	18	rats	rat	NOUN
njb-40	68	19	.	.	PUNCT
njb-40	69	1	on	on	ADP
njb-40	69	2	the	the	DET
njb-40	69	3	other	other	ADJ
njb-40	69	4	hand	hand	NOUN
njb-40	69	5	,	,	PUNCT
njb-40	69	6	there	there	PRON
njb-40	69	7	was	be	VERB
njb-40	69	8	increase	increase	NOUN
njb-40	69	9	in	in	ADP
njb-40	69	10	body	body	NOUN
njb-40	69	11	weight	weight	NOUN
njb-40	69	12	among	among	ADP
njb-40	69	13	the	the	DET
njb-40	69	14	midterm	midterm	NOUN
njb-40	69	15	rats	rat	NOUN
njb-40	69	16	in	in	ADP
njb-40	69	17	comparison	comparison	NOUN
njb-40	69	18	to	to	ADP
njb-40	69	19	its	its	PRON
njb-40	69	20	initial	initial	ADJ
njb-40	69	21	body	body	NOUN
njb-40	69	22	weight	weight	NOUN
njb-40	69	23	,	,	PUNCT
njb-40	69	24	as	as	ADV
njb-40	69	25	well	well	ADV
njb-40	69	26	as	as	ADP
njb-40	69	27	in	in	ADP
njb-40	69	28	controls	control	NOUN
njb-40	69	29	.	.	PUNCT
njb-40	70	1	various	various	ADJ
njb-40	70	2	anatomical	anatomical	ADJ
njb-40	70	3	parameters	parameter	NOUN
njb-40	70	4	in	in	ADP
njb-40	70	5	experimental	experimental	ADJ
njb-40	70	6	groups	group	NOUN
njb-40	70	7	and	and	CCONJ
njb-40	70	8	controls	control	NOUN
njb-40	70	9	are	be	AUX
njb-40	70	10	shown	show	VERB
njb-40	70	11	in	in	ADP
njb-40	70	12	table	table	NOUN
njb-40	70	13	1	1	NUM
njb-40	70	14	.	.	PUNCT
njb-40	71	1	no	no	DET
njb-40	71	2	significant	significant	ADJ
njb-40	71	3	difference	difference	NOUN
njb-40	71	4	in	in	ADP
njb-40	71	5	right	right	ADJ
njb-40	71	6	testis	testis	NOUN
njb-40	71	7	weight	weight	NOUN
njb-40	71	8	(	(	PUNCT
njb-40	71	9	p=0.184	p=0.184	ADJ
njb-40	71	10	)	)	PUNCT
njb-40	71	11	,	,	PUNCT
njb-40	71	12	left	leave	VERB
njb-40	71	13	testis	testis	NOUN
njb-40	71	14	weight	weight	NOUN
njb-40	71	15	(	(	PUNCT
njb-40	71	16	p=0.179	p=0.179	X
njb-40	71	17	)	)	PUNCT
njb-40	71	18	,	,	PUNCT
njb-40	71	19	and	and	CCONJ
njb-40	71	20	testicular	testicular	NOUN
njb-40	71	21	volume	volume	NOUN
njb-40	71	22	(	(	PUNCT
njb-40	71	23	p=0.388	p=0.388	PROPN
njb-40	71	24	)	)	PUNCT
njb-40	71	25	,	,	PUNCT
njb-40	71	26	but	but	CCONJ
njb-40	71	27	significant	significant	ADJ
njb-40	71	28	difference	difference	NOUN
njb-40	71	29	in	in	ADP
njb-40	71	30	diameters	diameter	NOUN
njb-40	71	31	(	(	PUNCT
njb-40	71	32	p=0.029	p=0.029	NOUN
njb-40	71	33	)	)	PUNCT
njb-40	71	34	and	and	CCONJ
njb-40	71	35	cross	cross	ADJ
njb-40	71	36	-	-	ADJ
njb-40	71	37	sectional	sectional	ADJ
njb-40	71	38	area	area	NOUN
njb-40	71	39	(	(	PUNCT
njb-40	71	40	p=0.028	p=0.028	NOUN
njb-40	71	41	)	)	PUNCT
njb-40	71	42	of	of	ADP
njb-40	71	43	seminiferous	seminiferous	ADJ
njb-40	71	44	tubules	tubule	NOUN
njb-40	71	45	,	,	PUNCT
njb-40	71	46	were	be	AUX
njb-40	71	47	observed	observe	VERB
njb-40	71	48	between	between	ADP
njb-40	71	49	short	short	ADJ
njb-40	71	50	term	term	NOUN
njb-40	71	51	experimental	experimental	ADJ
njb-40	71	52	and	and	CCONJ
njb-40	71	53	short	short	ADJ
njb-40	71	54	term	term	NOUN
njb-40	71	55	control	control	NOUN
njb-40	71	56	rats	rat	NOUN
njb-40	71	57	.	.	PUNCT
njb-40	72	1	however	however	ADV
njb-40	72	2	,	,	PUNCT
njb-40	72	3	a	a	DET
njb-40	72	4	significant	significant	ADJ
njb-40	72	5	difference	difference	NOUN
njb-40	72	6	in	in	ADP
njb-40	72	7	right	right	ADJ
njb-40	72	8	testis	testis	NOUN
njb-40	72	9	weight	weight	NOUN
njb-40	72	10	(	(	PUNCT
njb-40	72	11	p<0.001	p<0.001	NUM
njb-40	72	12	)	)	PUNCT
njb-40	72	13	,	,	PUNCT
njb-40	72	14	left	leave	VERB
njb-40	72	15	testis	testis	NOUN
njb-40	72	16	weight	weight	NOUN
njb-40	72	17	(	(	PUNCT
njb-40	72	18	p<0.001	p<0.001	NUM
njb-40	72	19	)	)	PUNCT
njb-40	72	20	,	,	PUNCT
njb-40	72	21	volume	volume	NOUN
njb-40	72	22	of	of	ADP
njb-40	72	23	testis	testis	NOUN
njb-40	72	24	(	(	PUNCT
njb-40	72	25	p<0.001	p<0.001	NUM
njb-40	72	26	)	)	PUNCT
njb-40	72	27	,	,	PUNCT
njb-40	72	28	diameter	diameter	NOUN
njb-40	72	29	(	(	PUNCT
njb-40	72	30	p<0.001	p<0.001	NUM
njb-40	72	31	)	)	PUNCT
njb-40	72	32	and	and	CCONJ
njb-40	72	33	area	area	NOUN
njb-40	72	34	(	(	PUNCT
njb-40	72	35	p<0.001	p<0.001	NOUN
njb-40	72	36	)	)	PUNCT
njb-40	72	37	of	of	ADP
njb-40	72	38	seminiferous	seminiferous	ADJ
njb-40	72	39	tubules	tubule	NOUN
njb-40	72	40	was	be	AUX
njb-40	72	41	observed	observe	VERB
njb-40	72	42	between	between	ADP
njb-40	72	43	midterm	midterm	NOUN
njb-40	72	44	experimental	experimental	ADJ
njb-40	72	45	and	and	CCONJ
njb-40	72	46	midterm	midterm	NOUN
njb-40	72	47	control	control	NOUN
njb-40	72	48	group	group	NOUN
njb-40	72	49	.	.	PUNCT
njb-40	73	1	similarly	similarly	ADV
njb-40	73	2	significant	significant	ADJ
njb-40	73	3	difference	difference	NOUN
njb-40	73	4	in	in	ADP
njb-40	73	5	right	right	ADJ
njb-40	73	6	testis	testis	NOUN
njb-40	73	7	weight	weight	NOUN
njb-40	73	8	(	(	PUNCT
njb-40	73	9	p<0.001	p<0.001	NUM
njb-40	73	10	)	)	PUNCT
njb-40	73	11	,	,	PUNCT
njb-40	73	12	left	leave	VERB
njb-40	73	13	testis	testis	NOUN
njb-40	73	14	weight	weight	NOUN
njb-40	73	15	(	(	PUNCT
njb-40	73	16	p<0.001	p<0.001	NUM
njb-40	73	17	)	)	PUNCT
njb-40	73	18	,	,	PUNCT
njb-40	73	19	volume	volume	NOUN
njb-40	73	20	of	of	ADP
njb-40	73	21	testes	testis	NOUN
njb-40	73	22	(	(	PUNCT
njb-40	73	23	p=0.038	p=0.038	NOUN
njb-40	73	24	)	)	PUNCT
njb-40	73	25	,	,	PUNCT
njb-40	73	26	and	and	CCONJ
njb-40	73	27	diameter	diameter	NOUN
njb-40	73	28	(	(	PUNCT
njb-40	73	29	p<0.001	p<0.001	NUM
njb-40	73	30	)	)	PUNCT
njb-40	73	31	and	and	CCONJ
njb-40	73	32	area	area	NOUN
njb-40	73	33	(	(	PUNCT
njb-40	73	34	p<0.001	p<0.001	NOUN
njb-40	73	35	)	)	PUNCT
njb-40	73	36	of	of	ADP
njb-40	73	37	seminiferous	seminiferous	ADJ
njb-40	73	38	tubules	tubule	NOUN
njb-40	73	39	was	be	AUX
njb-40	73	40	observed	observe	VERB
njb-40	73	41	between	between	ADP
njb-40	73	42	long	long	ADJ
njb-40	73	43	term	term	NOUN
njb-40	73	44	experimental	experimental	ADJ
njb-40	73	45	and	and	CCONJ
njb-40	73	46	long	long	ADJ
njb-40	73	47	term	term	NOUN
njb-40	73	48	control	control	NOUN
njb-40	73	49	group	group	NOUN
njb-40	73	50	.	.	PUNCT
njb-40	74	1	as	as	SCONJ
njb-40	74	2	compared	compare	VERB
njb-40	74	3	to	to	ADP
njb-40	74	4	short	short	ADJ
njb-40	74	5	term	term	NOUN
njb-40	74	6	experimental	experimental	ADJ
njb-40	74	7	group	group	NOUN
njb-40	74	8	,	,	PUNCT
njb-40	74	9	midterm	midterm	NOUN
njb-40	74	10	experimental	experimental	ADJ
njb-40	74	11	group	group	NOUN
njb-40	74	12	and	and	CCONJ
njb-40	74	13	long	long	ADJ
njb-40	74	14	term	term	NOUN
njb-40	74	15	experimental	experimental	ADJ
njb-40	74	16	group	group	NOUN
njb-40	74	17	had	have	VERB
njb-40	74	18	significantly	significantly	ADV
njb-40	74	19	lower	low	ADJ
njb-40	74	20	right	right	ADJ
njb-40	74	21	testis	testis	NOUN
njb-40	74	22	weight	weight	NOUN
njb-40	74	23	(	(	PUNCT
njb-40	74	24	p<0.001	p<0.001	NUM
njb-40	74	25	for	for	ADP
njb-40	74	26	both	both	PRON
njb-40	74	27	)	)	PUNCT
njb-40	74	28	,	,	PUNCT
njb-40	74	29	left	leave	VERB
njb-40	74	30	testis	testis	NOUN
njb-40	74	31	weight	weight	NOUN
njb-40	74	32	(	(	PUNCT
njb-40	74	33	p<0.001	p<0.001	NUM
njb-40	74	34	for	for	ADP
njb-40	74	35	both	both	PRON
njb-40	74	36	)	)	PUNCT
njb-40	74	37	,	,	PUNCT
njb-40	74	38	diameter	diameter	NOUN
njb-40	74	39	of	of	ADP
njb-40	74	40	seminiferous	seminiferous	ADJ
njb-40	74	41	tubule	tubule	NOUN
njb-40	74	42	(	(	PUNCT
njb-40	74	43	p<0.001	p<0.001	VERB
njb-40	74	44	for	for	ADP
njb-40	74	45	both	both	PRON
njb-40	74	46	)	)	PUNCT
njb-40	74	47	and	and	CCONJ
njb-40	74	48	cross	cross	ADJ
njb-40	74	49	-	-	ADJ
njb-40	74	50	sectional	sectional	ADJ
njb-40	74	51	area	area	NOUN
njb-40	74	52	of	of	ADP
njb-40	74	53	seminiferous	seminiferous	ADJ
njb-40	74	54	tubule	tubule	NOUN
njb-40	74	55	(	(	PUNCT
njb-40	74	56	p<0.001	p<0.001	NOUN
njb-40	74	57	both	both	PRON
njb-40	74	58	)	)	PUNCT
njb-40	74	59	.	.	PUNCT
njb-40	75	1	however	however	ADV
njb-40	75	2	,	,	PUNCT
njb-40	75	3	no	no	DET
njb-40	75	4	significant	significant	ADJ
njb-40	75	5	difference	difference	NOUN
njb-40	75	6	were	be	AUX
njb-40	75	7	observed	observe	VERB
njb-40	75	8	among	among	ADP
njb-40	75	9	midterm	midterm	NOUN
njb-40	75	10	and	and	CCONJ
njb-40	75	11	long	long	ADJ
njb-40	75	12	term	term	NOUN
njb-40	75	13	experimental	experimental	ADJ
njb-40	75	14	group	group	NOUN
njb-40	75	15	in	in	ADP
njb-40	75	16	terms	term	NOUN
njb-40	75	17	of	of	ADP
njb-40	75	18	testis	testis	NOUN
njb-40	75	19	weight	weight	NOUN
njb-40	75	20	,	,	PUNCT
njb-40	75	21	volume	volume	NOUN
njb-40	75	22	,	,	PUNCT
njb-40	75	23	diameter	diameter	NOUN
njb-40	75	24	and	and	CCONJ
njb-40	75	25	crosssectional	crosssectional	ADJ
njb-40	75	26	area	area	NOUN
njb-40	75	27	of	of	ADP
njb-40	75	28	seminiferous	seminiferous	ADJ
njb-40	75	29	tubules	tubule	NOUN
njb-40	75	30	.	.	PUNCT
njb-40	76	1	figure	figure	NOUN
njb-40	76	2	1	1	NUM
njb-40	76	3	(	(	PUNCT
njb-40	76	4	a	a	PRON
njb-40	76	5	,	,	PUNCT
njb-40	76	6	b	b	PROPN
njb-40	76	7	,	,	PUNCT
njb-40	76	8	c	c	NOUN
njb-40	76	9	and	and	CCONJ
njb-40	76	10	d	d	NOUN
njb-40	76	11	)	)	PUNCT
njb-40	76	12	shows	show	VERB
njb-40	76	13	the	the	DET
njb-40	76	14	cross	cross	NOUN
njb-40	76	15	-	-	NOUN
njb-40	76	16	section	section	NOUN
njb-40	76	17	of	of	ADP
njb-40	76	18	seminiferous	seminiferous	ADJ
njb-40	76	19	tubules	tubule	NOUN
njb-40	76	20	of	of	ADP
njb-40	76	21	control	control	NOUN
njb-40	76	22	and	and	CCONJ
njb-40	76	23	various	various	ADJ
njb-40	76	24	experimental	experimental	ADJ
njb-40	76	25	groups	group	NOUN
njb-40	76	26	.	.	PUNCT
njb-40	77	1	it	it	PRON
njb-40	77	2	was	be	AUX
njb-40	77	3	observed	observe	VERB
njb-40	77	4	that	that	SCONJ
njb-40	77	5	the	the	DET
njb-40	77	6	crosssections	crosssection	NOUN
njb-40	77	7	of	of	ADP
njb-40	77	8	the	the	DET
njb-40	77	9	seminiferous	seminiferous	ADJ
njb-40	77	10	tubules	tubule	NOUN
njb-40	77	11	of	of	ADP
njb-40	77	12	all	all	DET
njb-40	77	13	the	the	DET
njb-40	77	14	control	control	NOUN
njb-40	77	15	groups	group	NOUN
njb-40	77	16	were	be	AUX
njb-40	77	17	moderately	moderately	ADV
njb-40	77	18	circular	circular	ADJ
njb-40	77	19	or	or	CCONJ
njb-40	77	20	oval	oval	ADJ
njb-40	77	21	in	in	ADP
njb-40	77	22	outline	outline	NOUN
njb-40	77	23	with	with	ADP
njb-40	77	24	normal	normal	ADJ
njb-40	77	25	seminiferous	seminiferous	ADJ
njb-40	77	26	epithelium	epithelium	NOUN
njb-40	77	27	and	and	CCONJ
njb-40	77	28	numerous	numerous	ADJ
njb-40	77	29	spermatozoans	spermatozoans	PROPN
njb-40	77	30	within	within	ADP
njb-40	77	31	their	their	PRON
njb-40	77	32	lumen	luman	NOUN
njb-40	77	33	.	.	PUNCT
njb-40	78	1	the	the	DET
njb-40	78	2	interstitial	interstitial	ADJ
njb-40	78	3	cells	cell	NOUN
njb-40	78	4	were	be	AUX
njb-40	78	5	also	also	ADV
njb-40	78	6	normal	normal	ADJ
njb-40	78	7	and	and	CCONJ
njb-40	78	8	prominent	prominent	ADJ
njb-40	78	9	.	.	PUNCT
njb-40	79	1	rats	rat	NOUN
njb-40	79	2	that	that	PRON
njb-40	79	3	were	be	AUX
njb-40	79	4	given	give	VERB
njb-40	79	5	doxorubicin	doxorubicin	PROPN
njb-40	79	6	showed	show	VERB
njb-40	79	7	progressive	progressive	ADJ
njb-40	79	8	degenerations	degeneration	NOUN
njb-40	79	9	in	in	ADP
njb-40	79	10	their	their	PRON
njb-40	79	11	seminiferous	seminiferous	ADJ
njb-40	79	12	tubules	tubule	NOUN
njb-40	79	13	lumen	luman	NOUN
njb-40	79	14	.	.	PUNCT
njb-40	80	1	group	group	NOUN
njb-40	80	2	1	1	NUM
njb-40	80	3	rats	rat	NOUN
njb-40	80	4	showed	show	VERB
njb-40	80	5	a	a	DET
njb-40	80	6	little	little	ADJ
njb-40	80	7	reduction	reduction	NOUN
njb-40	80	8	in	in	ADP
njb-40	80	9	the	the	DET
njb-40	80	10	basal	basal	ADJ
njb-40	80	11	epithelial	epithelial	ADJ
njb-40	80	12	layer	layer	NOUN
njb-40	80	13	resulting	result	VERB
njb-40	80	14	in	in	ADP
njb-40	80	15	the	the	DET
njb-40	80	16	apparent	apparent	ADJ
njb-40	80	17	detachment	detachment	NOUN
njb-40	80	18	of	of	ADP
njb-40	80	19	the	the	DET
njb-40	80	20	basement	basement	NOUN
njb-40	80	21	membrane	membrane	NOUN
njb-40	80	22	.	.	PUNCT
njb-40	81	1	the	the	DET
njb-40	81	2	rats	rat	NOUN
njb-40	81	3	of	of	ADP
njb-40	81	4	group	group	NOUN
njb-40	81	5	2	2	NUM
njb-40	81	6	(	(	PUNCT
njb-40	81	7	midterm	midterm	NOUN
njb-40	81	8	experimental	experimental	ADJ
njb-40	81	9	group	group	NOUN
njb-40	81	10	)	)	PUNCT
njb-40	81	11	showed	show	VERB
njb-40	81	12	vacuolization	vacuolization	NOUN
njb-40	81	13	of	of	ADP
njb-40	81	14	the	the	DET
njb-40	81	15	cells	cell	NOUN
njb-40	81	16	,	,	PUNCT
njb-40	81	17	reduction	reduction	NOUN
njb-40	81	18	in	in	ADP
njb-40	81	19	the	the	DET
njb-40	81	20	number	number	NOUN
njb-40	81	21	of	of	ADP
njb-40	81	22	spermatozoa	spermatozoon	NOUN
njb-40	81	23	.	.	PUNCT
njb-40	82	1	lumen	luman	NOUN
njb-40	82	2	of	of	ADP
njb-40	82	3	the	the	DET
njb-40	82	4	seminiferous	seminiferous	ADJ
njb-40	82	5	tubules	tubule	NOUN
njb-40	82	6	was	be	AUX
njb-40	82	7	significantly	significantly	ADV
njb-40	82	8	vacant	vacant	ADJ
njb-40	82	9	.	.	PUNCT
njb-40	83	1	the	the	DET
njb-40	83	2	interstitial	interstitial	ADJ
njb-40	83	3	spaces	space	NOUN
njb-40	83	4	were	be	AUX
njb-40	83	5	distinct	distinct	ADJ
njb-40	83	6	.	.	PUNCT
njb-40	84	1	group	group	NOUN
njb-40	84	2	3	3	NUM
njb-40	84	3	rats	rat	NOUN
njb-40	84	4	(	(	PUNCT
njb-40	84	5	long	long	ADJ
njb-40	84	6	term	term	NOUN
njb-40	84	7	experimental	experimental	ADJ
njb-40	84	8	group	group	NOUN
njb-40	84	9	)	)	PUNCT
njb-40	84	10	showed	show	VERB
njb-40	84	11	marked	marked	ADJ
njb-40	84	12	variation	variation	NOUN
njb-40	84	13	in	in	ADP
njb-40	84	14	its	its	PRON
njb-40	84	15	architecture	architecture	NOUN
njb-40	84	16	.	.	PUNCT
njb-40	85	1	there	there	PRON
njb-40	85	2	was	be	VERB
njb-40	85	3	much	much	ADJ
njb-40	85	4	testicular	testicular	NOUN
njb-40	85	5	atrophy	atrophy	NOUN
njb-40	85	6	and	and	CCONJ
njb-40	85	7	most	most	ADJ
njb-40	85	8	of	of	ADP
njb-40	85	9	the	the	DET
njb-40	85	10	spaces	space	NOUN
njb-40	85	11	were	be	AUX
njb-40	85	12	occupied	occupy	VERB
njb-40	85	13	by	by	ADP
njb-40	85	14	the	the	DET
njb-40	85	15	interstitial	interstitial	ADJ
njb-40	85	16	cells	cell	NOUN
njb-40	85	17	.	.	PUNCT
njb-40	86	1	nepal	nepal	ADJ
njb-40	86	2	journal	journal	PROPN
njb-40	86	3	of	of	ADP
njb-40	86	4	biotechnology	biotechnology	NOUN
njb-40	86	5	.	.	PUNCT
njb-40	87	1	d	d	X
njb-40	87	2	e	e	PROPN
njb-40	87	3	c	c	PROPN
njb-40	87	4	.	.	PUNCT
njb-40	88	1	2	2	NUM
njb-40	88	2	0	0	NUM
njb-40	88	3	1	1	NUM
njb-40	88	4	5	5	NUM
njb-40	88	5	vol	vol	NOUN
njb-40	88	6	.	.	PUNCT
njb-40	89	1	3	3	NUM
njb-40	89	2	,	,	PUNCT
njb-40	89	3	no	no	INTJ
njb-40	89	4	.	.	PUNCT
njb-40	90	1	1:10	1:10	NUM
njb-40	90	2	-	-	SYM
njb-40	90	3	14	14	NUM
njb-40	90	4	sah	sah	PROPN
njb-40	90	5	et	et	PROPN
njb-40	90	6	al	al	PROPN
njb-40	90	7	.	.	PUNCT
njb-40	91	1	©	©	PROPN
njb-40	91	2	njb	njb	PROPN
njb-40	91	3	,	,	PUNCT
njb-40	91	4	biotechnology	biotechnology	NOUN
njb-40	91	5	society	society	NOUN
njb-40	91	6	of	of	ADP
njb-40	91	7	nepal	nepal	ADJ
njb-40	91	8	13	13	NUM
njb-40	91	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	ADJ
njb-40	91	10	figure	figure	NOUN
njb-40	91	11	1	1	NUM
njb-40	91	12	.	.	PUNCT
njb-40	92	1	a	a	PRON
njb-40	92	2	,	,	PUNCT
njb-40	92	3	b	b	PROPN
njb-40	92	4	,	,	PUNCT
njb-40	92	5	c	c	NOUN
njb-40	92	6	and	and	CCONJ
njb-40	92	7	d	d	NOUN
njb-40	92	8	show	show	VERB
njb-40	92	9	the	the	DET
njb-40	92	10	cross	cross	NOUN
njb-40	92	11	-	-	NOUN
njb-40	92	12	section	section	NOUN
njb-40	92	13	of	of	ADP
njb-40	92	14	seminiferous	seminiferous	ADJ
njb-40	92	15	tubules	tubule	NOUN
njb-40	92	16	of	of	ADP
njb-40	92	17	control	control	NOUN
njb-40	92	18	(	(	PUNCT
njb-40	92	19	all	all	DET
njb-40	92	20	control	control	NOUN
njb-40	92	21	groups	group	NOUN
njb-40	92	22	)	)	PUNCT
njb-40	92	23	,	,	PUNCT
njb-40	92	24	short	short	ADJ
njb-40	92	25	term	term	NOUN
njb-40	92	26	experimental	experimental	ADJ
njb-40	92	27	group	group	NOUN
njb-40	92	28	,	,	PUNCT
njb-40	92	29	midterm	midterm	NOUN
njb-40	92	30	experimental	experimental	ADJ
njb-40	92	31	group	group	NOUN
njb-40	92	32	and	and	CCONJ
njb-40	92	33	long	long	ADJ
njb-40	92	34	term	term	NOUN
njb-40	92	35	experimental	experimental	ADJ
njb-40	92	36	group	group	NOUN
njb-40	92	37	respectively	respectively	ADV
njb-40	92	38	.	.	PUNCT
njb-40	93	1	discussion	discussion	NOUN
njb-40	93	2	doxorubicin	doxorubicin	PROPN
njb-40	93	3	is	be	AUX
njb-40	93	4	one	one	NUM
njb-40	93	5	of	of	ADP
njb-40	93	6	the	the	DET
njb-40	93	7	most	most	ADV
njb-40	93	8	widely	widely	ADV
njb-40	93	9	used	use	VERB
njb-40	93	10	anticancer	anticancer	NOUN
njb-40	93	11	agents	agent	NOUN
njb-40	93	12	in	in	ADP
njb-40	93	13	the	the	DET
njb-40	93	14	clinic	clinic	NOUN
njb-40	93	15	despite	despite	SCONJ
njb-40	93	16	its	its	PRON
njb-40	93	17	dose	dose	NOUN
njb-40	93	18	–	–	PUNCT
njb-40	93	19	limiting	limit	VERB
njb-40	93	20	side	side	NOUN
njb-40	93	21	-	-	PUNCT
njb-40	93	22	effects	effect	NOUN
njb-40	93	23	.	.	PUNCT
njb-40	94	1	in	in	ADP
njb-40	94	2	the	the	DET
njb-40	94	3	present	present	ADJ
njb-40	94	4	study	study	NOUN
njb-40	94	5	,	,	PUNCT
njb-40	94	6	we	we	PRON
njb-40	94	7	assessed	assess	VERB
njb-40	94	8	the	the	DET
njb-40	94	9	effects	effect	NOUN
njb-40	94	10	of	of	ADP
njb-40	94	11	a	a	DET
njb-40	94	12	single	single	ADJ
njb-40	94	13	dose	dose	NOUN
njb-40	94	14	(	(	PUNCT
njb-40	94	15	i.e.	i.e.	X
njb-40	94	16	10mg	10mg	PROPN
njb-40	94	17	/	/	SYM
njb-40	94	18	kg	kg	NOUN
njb-40	94	19	body	body	NOUN
njb-40	94	20	weight	weight	NOUN
njb-40	94	21	of	of	ADP
njb-40	94	22	animal	animal	NOUN
njb-40	94	23	)	)	PUNCT
njb-40	94	24	of	of	ADP
njb-40	94	25	the	the	DET
njb-40	94	26	drug	drug	NOUN
njb-40	94	27	on	on	ADP
njb-40	94	28	male	male	ADJ
njb-40	94	29	albino	albino	NOUN
njb-40	94	30	rats	rat	NOUN
njb-40	94	31	.	.	PUNCT
njb-40	95	1	present	present	ADJ
njb-40	95	2	study	study	NOUN
njb-40	95	3	shows	show	VERB
njb-40	95	4	that	that	SCONJ
njb-40	95	5	weight	weight	NOUN
njb-40	95	6	of	of	ADP
njb-40	95	7	the	the	DET
njb-40	95	8	rats	rat	NOUN
njb-40	95	9	that	that	PRON
njb-40	95	10	were	be	AUX
njb-40	95	11	given	give	VERB
njb-40	95	12	doxorubicin	doxorubicin	PROPN
njb-40	95	13	decreases	decrease	NOUN
njb-40	95	14	in	in	ADP
njb-40	95	15	comparison	comparison	NOUN
njb-40	95	16	to	to	ADP
njb-40	95	17	the	the	DET
njb-40	95	18	control	control	NOUN
njb-40	95	19	groups	group	NOUN
njb-40	95	20	.	.	PUNCT
njb-40	96	1	the	the	DET
njb-40	96	2	decrease	decrease	NOUN
njb-40	96	3	in	in	ADP
njb-40	96	4	body	body	NOUN
njb-40	96	5	weight	weight	NOUN
njb-40	96	6	may	may	AUX
njb-40	96	7	be	be	AUX
njb-40	96	8	due	due	ADJ
njb-40	96	9	to	to	ADP
njb-40	96	10	loss	loss	NOUN
njb-40	96	11	of	of	ADP
njb-40	96	12	appetite	appetite	NOUN
njb-40	96	13	in	in	ADP
njb-40	96	14	experimental	experimental	ADJ
njb-40	96	15	rats	rat	NOUN
njb-40	96	16	.	.	PUNCT
njb-40	97	1	we	we	PRON
njb-40	97	2	however	however	ADV
njb-40	97	3	observed	observe	VERB
njb-40	97	4	that	that	SCONJ
njb-40	97	5	,	,	PUNCT
njb-40	97	6	the	the	DET
njb-40	97	7	midterm	midterm	NOUN
njb-40	97	8	experimental	experimental	ADJ
njb-40	97	9	rats	rat	NOUN
njb-40	97	10	showed	show	VERB
njb-40	97	11	increase	increase	NOUN
njb-40	97	12	in	in	ADP
njb-40	97	13	body	body	NOUN
njb-40	97	14	weight	weight	NOUN
njb-40	97	15	.	.	PUNCT
njb-40	98	1	the	the	DET
njb-40	98	2	increase	increase	NOUN
njb-40	98	3	in	in	ADP
njb-40	98	4	body	body	NOUN
njb-40	98	5	weight	weight	NOUN
njb-40	98	6	in	in	ADP
njb-40	98	7	midterm	midterm	NOUN
njb-40	98	8	might	might	AUX
njb-40	98	9	be	be	AUX
njb-40	98	10	due	due	ADJ
njb-40	98	11	to	to	ADP
njb-40	98	12	the	the	DET
njb-40	98	13	reversible	reversible	ADJ
njb-40	98	14	metabolic	metabolic	ADJ
njb-40	98	15	changes	change	NOUN
njb-40	98	16	caused	cause	VERB
njb-40	98	17	by	by	ADP
njb-40	98	18	the	the	DET
njb-40	98	19	drug	drug	NOUN
njb-40	98	20	.	.	PUNCT
njb-40	99	1	after	after	ADP
njb-40	99	2	some	some	DET
njb-40	99	3	period	period	NOUN
njb-40	99	4	of	of	ADP
njb-40	99	5	time	time	NOUN
njb-40	99	6	the	the	DET
njb-40	99	7	body	body	NOUN
njb-40	99	8	regains	regain	VERB
njb-40	99	9	its	its	PRON
njb-40	99	10	metabolic	metabolic	ADJ
njb-40	99	11	function	function	NOUN
njb-40	99	12	and	and	CCONJ
njb-40	99	13	then	then	ADV
njb-40	99	14	it	it	PRON
njb-40	99	15	again	again	ADV
njb-40	99	16	decreases	decrease	VERB
njb-40	99	17	due	due	ADJ
njb-40	99	18	to	to	ADP
njb-40	99	19	the	the	DET
njb-40	99	20	long	long	ADJ
njb-40	99	21	term	term	NOUN
njb-40	99	22	effect	effect	NOUN
njb-40	99	23	of	of	ADP
njb-40	99	24	the	the	DET
njb-40	99	25	drugs	drug	NOUN
njb-40	99	26	.	.	PUNCT
njb-40	100	1	in	in	ADP
njb-40	100	2	the	the	DET
njb-40	100	3	present	present	ADJ
njb-40	100	4	study	study	NOUN
njb-40	100	5	significant	significant	ADJ
njb-40	100	6	difference	difference	NOUN
njb-40	100	7	in	in	ADP
njb-40	100	8	testicular	testicular	NOUN
njb-40	100	9	weight	weight	NOUN
njb-40	100	10	among	among	ADP
njb-40	100	11	the	the	DET
njb-40	100	12	midterm	midterm	NOUN
njb-40	100	13	experimental	experimental	ADJ
njb-40	100	14	and	and	CCONJ
njb-40	100	15	the	the	DET
njb-40	100	16	midterm	midterm	NOUN
njb-40	100	17	control	control	NOUN
njb-40	100	18	groups	group	NOUN
njb-40	100	19	,	,	PUNCT
njb-40	100	20	and	and	CCONJ
njb-40	100	21	among	among	ADP
njb-40	100	22	the	the	DET
njb-40	100	23	long	long	ADJ
njb-40	100	24	term	term	NOUN
njb-40	100	25	experimental	experimental	ADJ
njb-40	100	26	and	and	CCONJ
njb-40	100	27	the	the	DET
njb-40	100	28	long	long	ADJ
njb-40	100	29	term	term	NOUN
njb-40	100	30	control	control	NOUN
njb-40	100	31	groups	group	NOUN
njb-40	100	32	was	be	AUX
njb-40	100	33	observed	observe	VERB
njb-40	100	34	,	,	PUNCT
njb-40	100	35	which	which	PRON
njb-40	100	36	is	be	AUX
njb-40	100	37	similar	similar	ADJ
njb-40	100	38	to	to	ADP
njb-40	100	39	the	the	DET
njb-40	100	40	findings	finding	NOUN
njb-40	100	41	of	of	ADP
njb-40	100	42	saalu	saalu	PROPN
njb-40	100	43	et	et	PROPN
njb-40	100	44	al	al	PROPN
njb-40	101	1	[	[	PUNCT
njb-40	101	2	7	7	NUM
njb-40	101	3	]	]	PUNCT
njb-40	101	4	.	.	PUNCT
njb-40	102	1	we	we	PRON
njb-40	102	2	also	also	ADV
njb-40	102	3	observed	observe	VERB
njb-40	102	4	progressive	progressive	ADJ
njb-40	102	5	decrease	decrease	NOUN
njb-40	102	6	in	in	ADP
njb-40	102	7	testis	testis	NOUN
njb-40	102	8	weight	weight	NOUN
njb-40	102	9	from	from	ADP
njb-40	102	10	short	short	ADJ
njb-40	102	11	term	term	NOUN
njb-40	102	12	to	to	ADP
njb-40	102	13	long	long	ADJ
njb-40	102	14	term	term	NOUN
njb-40	102	15	experimental	experimental	ADJ
njb-40	102	16	group	group	NOUN
njb-40	102	17	.	.	PUNCT
njb-40	103	1	previous	previous	ADJ
njb-40	103	2	study	study	NOUN
njb-40	103	3	done	do	VERB
njb-40	103	4	by	by	ADP
njb-40	103	5	howell	howell	PROPN
njb-40	103	6	et	et	PROPN
njb-40	103	7	al	al	PROPN
njb-40	103	8	.	.	PROPN
njb-40	103	9	also	also	ADV
njb-40	103	10	reported	report	VERB
njb-40	103	11	that	that	SCONJ
njb-40	103	12	administration	administration	NOUN
njb-40	103	13	of	of	ADP
njb-40	103	14	doxorubicin	doxorubicin	PROPN
njb-40	103	15	can	can	AUX
njb-40	103	16	decrease	decrease	VERB
njb-40	103	17	the	the	DET
njb-40	103	18	testicular	testicular	NOUN
njb-40	103	19	weight	weight	NOUN
njb-40	103	20	of	of	ADP
njb-40	103	21	the	the	DET
njb-40	103	22	rats	rat	NOUN
njb-40	103	23	.	.	PUNCT
njb-40	104	1	this	this	PRON
njb-40	104	2	could	could	AUX
njb-40	104	3	be	be	AUX
njb-40	104	4	due	due	ADJ
njb-40	104	5	to	to	ADP
njb-40	104	6	the	the	DET
njb-40	104	7	severe	severe	ADJ
njb-40	104	8	parenchymal	parenchymal	ADJ
njb-40	104	9	atrophy	atrophy	NOUN
njb-40	104	10	in	in	ADP
njb-40	104	11	the	the	DET
njb-40	104	12	seminiferous	seminiferous	ADJ
njb-40	104	13	tubules	tubule	NOUN
njb-40	104	14	following	follow	VERB
njb-40	104	15	the	the	DET
njb-40	104	16	doxorubicin	doxorubicin	PROPN
njb-40	104	17	administration	administration	NOUN
njb-40	104	18	[	[	PUNCT
njb-40	104	19	8	8	NUM
njb-40	104	20	]	]	PUNCT
njb-40	104	21	.	.	PUNCT
njb-40	105	1	however	however	ADV
njb-40	105	2	study	study	NOUN
njb-40	105	3	by	by	ADP
njb-40	105	4	prahalathan	prahalathan	PROPN
njb-40	105	5	et	et	PROPN
njb-40	105	6	al	al	PROPN
njb-40	105	7	.	.	PROPN
njb-40	105	8	did	do	AUX
njb-40	105	9	not	not	PART
njb-40	105	10	report	report	VERB
njb-40	105	11	any	any	DET
njb-40	105	12	significant	significant	ADJ
njb-40	105	13	testicular	testicular	NOUN
njb-40	105	14	weight	weight	NOUN
njb-40	105	15	changes	change	NOUN
njb-40	105	16	with	with	ADP
njb-40	105	17	doxorubicin	doxorubicin	PROPN
njb-40	105	18	treatment	treatment	NOUN
njb-40	105	19	[	[	X
njb-40	105	20	9	9	NUM
njb-40	105	21	]	]	PUNCT
njb-40	105	22	.	.	PUNCT
njb-40	106	1	in	in	ADP
njb-40	106	2	the	the	DET
njb-40	106	3	present	present	ADJ
njb-40	106	4	study	study	NOUN
njb-40	106	5	,	,	PUNCT
njb-40	106	6	we	we	PRON
njb-40	106	7	found	find	VERB
njb-40	106	8	that	that	SCONJ
njb-40	106	9	the	the	DET
njb-40	106	10	diameter	diameter	NOUN
njb-40	106	11	and	and	CCONJ
njb-40	106	12	cross	cross	ADJ
njb-40	106	13	-	-	ADJ
njb-40	106	14	sectional	sectional	ADJ
njb-40	106	15	area	area	NOUN
njb-40	106	16	of	of	ADP
njb-40	106	17	seminiferous	seminiferous	ADJ
njb-40	106	18	tubules	tubule	NOUN
njb-40	106	19	decreases	decrease	VERB
njb-40	106	20	with	with	ADP
njb-40	106	21	the	the	DET
njb-40	106	22	time	time	NOUN
njb-40	106	23	in	in	ADP
njb-40	106	24	the	the	DET
njb-40	106	25	rats	rat	NOUN
njb-40	106	26	given	give	VERB
njb-40	106	27	doxorubicin	doxorubicin	PROPN
njb-40	106	28	.	.	PUNCT
njb-40	107	1	as	as	SCONJ
njb-40	107	2	compared	compare	VERB
njb-40	107	3	to	to	ADP
njb-40	107	4	short	short	ADJ
njb-40	107	5	term	term	NOUN
njb-40	107	6	experimental	experimental	ADJ
njb-40	107	7	group	group	NOUN
njb-40	107	8	,	,	PUNCT
njb-40	107	9	midterm	midterm	NOUN
njb-40	107	10	experimental	experimental	ADJ
njb-40	107	11	group	group	NOUN
njb-40	107	12	and	and	CCONJ
njb-40	107	13	long	long	ADJ
njb-40	107	14	term	term	NOUN
njb-40	107	15	experimental	experimental	ADJ
njb-40	107	16	group	group	NOUN
njb-40	107	17	have	have	AUX
njb-40	107	18	decreased	decrease	VERB
njb-40	107	19	diameter	diameter	NOUN
njb-40	107	20	and	and	CCONJ
njb-40	107	21	cross	cross	ADJ
njb-40	107	22	-	-	ADJ
njb-40	107	23	sectional	sectional	ADJ
njb-40	107	24	area	area	NOUN
njb-40	107	25	of	of	ADP
njb-40	107	26	the	the	DET
njb-40	107	27	seminiferous	seminiferous	ADJ
njb-40	107	28	tubules	tubule	NOUN
njb-40	107	29	,	,	PUNCT
njb-40	107	30	which	which	PRON
njb-40	107	31	may	may	AUX
njb-40	107	32	be	be	AUX
njb-40	107	33	due	due	ADJ
njb-40	107	34	to	to	ADP
njb-40	107	35	more	more	ADJ
njb-40	107	36	effect	effect	NOUN
njb-40	107	37	of	of	ADP
njb-40	107	38	the	the	DET
njb-40	107	39	drugs	drug	NOUN
njb-40	107	40	on	on	ADP
njb-40	107	41	exposure	exposure	NOUN
njb-40	107	42	to	to	ADP
njb-40	107	43	long	long	ADJ
njb-40	107	44	time	time	NOUN
njb-40	107	45	.	.	PUNCT
njb-40	108	1	our	our	PRON
njb-40	108	2	findings	finding	NOUN
njb-40	108	3	are	be	AUX
njb-40	108	4	in	in	ADP
njb-40	108	5	accord	accord	NOUN
njb-40	108	6	to	to	ADP
njb-40	108	7	previous	previous	ADJ
njb-40	108	8	study	study	NOUN
njb-40	108	9	by	by	ADP
njb-40	108	10	saalu	saalu	PROPN
njb-40	108	11	et	et	PROPN
njb-40	108	12	al	al	PROPN
njb-40	108	13	[	[	PUNCT
njb-40	108	14	7	7	NUM
njb-40	108	15	]	]	X
njb-40	108	16	.	.	PUNCT
njb-40	109	1	study	study	NOUN
njb-40	109	2	by	by	ADP
njb-40	109	3	saalu	saalu	PROPN
njb-40	109	4	et	et	PROPN
njb-40	109	5	al	al	PROPN
njb-40	109	6	.	.	PROPN
njb-40	109	7	reported	report	VERB
njb-40	109	8	that	that	SCONJ
njb-40	109	9	doxorubicin	doxorubicin	PROPN
njb-40	109	10	chemotherapy	chemotherapy	NOUN
njb-40	109	11	induces	induce	VERB
njb-40	109	12	morphological	morphological	ADJ
njb-40	109	13	and	and	CCONJ
njb-40	109	14	morphometric	morphometric	ADJ
njb-40	109	15	impairments	impairment	NOUN
njb-40	109	16	of	of	ADP
njb-40	109	17	testes	testis	NOUN
njb-40	109	18	of	of	ADP
njb-40	109	19	rats	rat	NOUN
njb-40	109	20	and	and	CCONJ
njb-40	109	21	progressive	progressive	ADJ
njb-40	109	22	worsening	worsening	NOUN
njb-40	109	23	of	of	ADP
njb-40	109	24	testicular	testicular	NOUN
njb-40	109	25	derangement	derangement	NOUN
njb-40	109	26	with	with	ADP
njb-40	109	27	time	time	NOUN
njb-40	109	28	following	follow	VERB
njb-40	109	29	a	a	DET
njb-40	109	30	single	single	ADJ
njb-40	109	31	dose	dose	NOUN
njb-40	109	32	of	of	ADP
njb-40	109	33	doxorubicin	doxorubicin	PROPN
njb-40	109	34	treatment	treatment	NOUN
njb-40	109	35	[	[	X
njb-40	109	36	7	7	NUM
njb-40	109	37	]	]	PUNCT
njb-40	109	38	.	.	PUNCT
njb-40	110	1	recent	recent	ADJ
njb-40	110	2	study	study	NOUN
njb-40	110	3	done	do	VERB
njb-40	110	4	in	in	ADP
njb-40	110	5	india	india	PROPN
njb-40	110	6	showed	show	VERB
njb-40	110	7	that	that	SCONJ
njb-40	110	8	treatment	treatment	NOUN
njb-40	110	9	with	with	ADP
njb-40	110	10	doxorubicin	doxorubicin	PROPN
njb-40	110	11	alone	alone	ADV
njb-40	110	12	caused	cause	VERB
njb-40	110	13	decrease	decrease	NOUN
njb-40	110	14	in	in	ADP
njb-40	110	15	body	body	NOUN
njb-40	110	16	weight	weight	NOUN
njb-40	110	17	,	,	PUNCT
njb-40	110	18	sperm	sperm	NOUN
njb-40	110	19	count	count	NOUN
njb-40	110	20	and	and	CCONJ
njb-40	110	21	serum	serum	NOUN
njb-40	110	22	testosterone	testosterone	NOUN
njb-40	110	23	and	and	CCONJ
njb-40	110	24	increase	increase	NOUN
njb-40	110	25	in	in	ADP
njb-40	110	26	serum	serum	NOUN
njb-40	110	27	level	level	NOUN
njb-40	110	28	of	of	ADP
njb-40	110	29	lactate	lactate	ADJ
njb-40	110	30	dehydrogenase	dehydrogenase	NOUN
njb-40	110	31	(	(	PUNCT
njb-40	110	32	ldh	ldh	NOUN
njb-40	110	33	)	)	PUNCT
njb-40	110	34	,	,	PUNCT
njb-40	110	35	creatine	creatine	VERB
njb-40	110	36	phosphokinase	phosphokinase	NOUN
njb-40	110	37	(	(	PUNCT
njb-40	110	38	ck	ck	INTJ
njb-40	110	39	)	)	PUNCT
njb-40	110	40	,	,	PUNCT
njb-40	110	41	and	and	CCONJ
njb-40	110	42	glutamic	glutamic	ADJ
njb-40	110	43	oxaloacetate	oxaloacetate	NOUN
njb-40	110	44	transaminase	transaminase	NOUN
njb-40	110	45	(	(	PUNCT
njb-40	110	46	got	get	VERB
njb-40	110	47	)	)	PUNCT
njb-40	110	48	[	[	X
njb-40	110	49	10	10	NUM
njb-40	110	50	]	]	PUNCT
njb-40	110	51	.	.	PUNCT
njb-40	111	1	in	in	ADP
njb-40	111	2	the	the	DET
njb-40	111	3	present	present	ADJ
njb-40	111	4	study	study	NOUN
njb-40	111	5	,	,	PUNCT
njb-40	111	6	we	we	PRON
njb-40	111	7	observed	observe	VERB
njb-40	111	8	deterioration	deterioration	NOUN
njb-40	111	9	in	in	ADP
njb-40	111	10	seminiferous	seminiferous	ADJ
njb-40	111	11	tubules	tubule	NOUN
njb-40	111	12	architecture	architecture	NOUN
njb-40	111	13	in	in	ADP
njb-40	111	14	experimental	experimental	ADJ
njb-40	111	15	group	group	NOUN
njb-40	111	16	,	,	PUNCT
njb-40	111	17	and	and	CCONJ
njb-40	111	18	the	the	DET
njb-40	111	19	architecture	architecture	NOUN
njb-40	111	20	was	be	AUX
njb-40	111	21	more	more	ADV
njb-40	111	22	impaired	impaired	ADJ
njb-40	111	23	in	in	ADP
njb-40	111	24	long	long	ADJ
njb-40	111	25	term	term	NOUN
njb-40	111	26	experimental	experimental	ADJ
njb-40	111	27	group	group	NOUN
njb-40	111	28	than	than	ADP
njb-40	111	29	midterm	midterm	NOUN
njb-40	111	30	and	and	CCONJ
njb-40	111	31	short	short	ADJ
njb-40	111	32	term	term	NOUN
njb-40	111	33	experimental	experimental	ADJ
njb-40	111	34	rats	rat	NOUN
njb-40	111	35	.	.	PUNCT
njb-40	112	1	the	the	DET
njb-40	112	2	study	study	NOUN
njb-40	112	3	also	also	ADV
njb-40	112	4	demonstrates	demonstrate	VERB
njb-40	112	5	that	that	SCONJ
njb-40	112	6	testicular	testicular	NOUN
njb-40	112	7	cytotoxicity	cytotoxicity	NOUN
njb-40	112	8	caused	cause	VERB
njb-40	112	9	by	by	ADP
njb-40	112	10	doxorubicin	doxorubicin	PROPN
njb-40	112	11	provokes	provokes	PROPN
njb-40	112	12	germ	germ	PROPN
njb-40	112	13	cell	cell	NOUN
njb-40	112	14	depletion	depletion	NOUN
njb-40	112	15	in	in	ADP
njb-40	112	16	the	the	DET
njb-40	112	17	seminiferous	seminiferous	ADJ
njb-40	112	18	epithelium	epithelium	NOUN
njb-40	112	19	of	of	ADP
njb-40	112	20	the	the	DET
njb-40	112	21	rats	rat	NOUN
njb-40	112	22	.	.	PUNCT
njb-40	113	1	saalu	saalu	PROPN
njb-40	113	2	et	et	PROPN
njb-40	113	3	al	al	PROPN
njb-40	113	4	.	.	PROPN
njb-40	113	5	showed	show	VERB
njb-40	113	6	that	that	SCONJ
njb-40	113	7	even	even	ADV
njb-40	113	8	a	a	DET
njb-40	113	9	single	single	ADJ
njb-40	113	10	dose	dose	NOUN
njb-40	113	11	of	of	ADP
njb-40	113	12	doxorubicin	doxorubicin	PROPN
njb-40	113	13	progressively	progressively	ADV
njb-40	113	14	causes	cause	VERB
njb-40	113	15	testicular	testicular	NOUN
njb-40	113	16	derangement	derangement	NOUN
njb-40	113	17	which	which	PRON
njb-40	113	18	may	may	AUX
njb-40	113	19	be	be	AUX
njb-40	113	20	due	due	ADJ
njb-40	113	21	to	to	ADP
njb-40	113	22	its	its	PRON
njb-40	113	23	capacity	capacity	NOUN
njb-40	113	24	to	to	PART
njb-40	113	25	generate	generate	VERB
njb-40	113	26	intracellular	intracellular	ADJ
njb-40	113	27	free	free	ADJ
njb-40	113	28	radicals	radical	NOUN
njb-40	113	29	and	and	CCONJ
njb-40	113	30	reactive	reactive	ADJ
njb-40	113	31	oxygen	oxygen	NOUN
njb-40	113	32	species	specie	NOUN
njb-40	113	33	[	[	PUNCT
njb-40	113	34	7	7	NUM
njb-40	113	35	]	]	PUNCT
njb-40	113	36	.	.	PUNCT
njb-40	114	1	single	single	ADJ
njb-40	114	2	higher	high	ADJ
njb-40	114	3	doses	dose	NOUN
njb-40	114	4	or	or	CCONJ
njb-40	114	5	multiple	multiple	ADJ
njb-40	114	6	lower	low	ADJ
njb-40	114	7	doses	dose	NOUN
njb-40	114	8	of	of	ADP
njb-40	114	9	doxorubicin	doxorubicin	PROPN
njb-40	114	10	have	have	AUX
njb-40	114	11	been	be	AUX
njb-40	114	12	referred	refer	VERB
njb-40	114	13	to	to	PART
njb-40	114	14	be	be	AUX
njb-40	114	15	toxic	toxic	ADJ
njb-40	114	16	to	to	ADP
njb-40	114	17	the	the	DET
njb-40	114	18	stem	stem	NOUN
njb-40	114	19	spermatogonia	spermatogonia	NOUN
njb-40	114	20	,	,	PUNCT
njb-40	114	21	diminishing	diminish	VERB
njb-40	114	22	their	their	PRON
njb-40	114	23	survival	survival	NOUN
njb-40	114	24	[	[	X
njb-40	114	25	11	11	NUM
njb-40	114	26	]	]	PUNCT
njb-40	114	27	.	.	PUNCT
njb-40	115	1	the	the	DET
njb-40	115	2	alteration	alteration	NOUN
njb-40	115	3	of	of	ADP
njb-40	115	4	the	the	DET
njb-40	115	5	measurements	measurement	NOUN
njb-40	115	6	of	of	ADP
njb-40	115	7	testicular	testicular	NOUN
njb-40	115	8	volume	volume	NOUN
njb-40	115	9	and	and	CCONJ
njb-40	115	10	weight	weight	NOUN
njb-40	115	11	,	,	PUNCT
njb-40	115	12	tubular	tubular	ADJ
njb-40	115	13	diameter	diameter	NOUN
njb-40	115	14	,	,	PUNCT
njb-40	115	15	seminiferous	seminiferous	ADJ
njb-40	115	16	epithelium	epithelium	NOUN
njb-40	115	17	height	height	NOUN
njb-40	115	18	and	and	CCONJ
njb-40	115	19	volume	volume	NOUN
njb-40	115	20	densities	density	NOUN
njb-40	115	21	of	of	ADP
njb-40	115	22	tubular	tubular	ADJ
njb-40	115	23	lumen	luman	NOUN
njb-40	115	24	and	and	CCONJ
njb-40	115	25	seminiferous	seminiferous	ADJ
njb-40	115	26	epithelium	epithelium	NOUN
njb-40	115	27	can	can	AUX
njb-40	115	28	give	give	VERB
njb-40	115	29	information	information	NOUN
njb-40	115	30	about	about	ADP
njb-40	115	31	the	the	DET
njb-40	115	32	testicular	testicular	NOUN
njb-40	115	33	damage	damage	NOUN
njb-40	115	34	degree	degree	NOUN
njb-40	115	35	as	as	ADP
njb-40	115	36	a	a	DET
njb-40	115	37	consequence	consequence	NOUN
njb-40	115	38	of	of	ADP
njb-40	115	39	germ	germ	NOUN
njb-40	115	40	cell	cell	NOUN
njb-40	115	41	death	death	NOUN
njb-40	115	42	[	[	PUNCT
njb-40	115	43	12	12	NUM
njb-40	115	44	]	]	PUNCT
njb-40	115	45	.	.	PUNCT
njb-40	116	1	franca	franca	NOUN
njb-40	116	2	et	et	PROPN
njb-40	116	3	al	al	PROPN
njb-40	116	4	.	.	PROPN
njb-40	116	5	nepal	nepal	PROPN
njb-40	116	6	journal	journal	PROPN
njb-40	116	7	of	of	ADP
njb-40	116	8	biotechnology	biotechnology	NOUN
njb-40	116	9	.	.	PUNCT
njb-40	117	1	d	d	X
njb-40	117	2	e	e	PROPN
njb-40	117	3	c	c	PROPN
njb-40	117	4	.	.	PUNCT
njb-40	118	1	2	2	NUM
njb-40	118	2	0	0	NUM
njb-40	118	3	1	1	NUM
njb-40	118	4	5	5	NUM
njb-40	118	5	vol	vol	NOUN
njb-40	118	6	.	.	PUNCT
njb-40	119	1	3	3	NUM
njb-40	119	2	,	,	PUNCT
njb-40	119	3	no	no	INTJ
njb-40	119	4	.	.	PUNCT
njb-40	120	1	1:10	1:10	NUM
njb-40	120	2	-	-	SYM
njb-40	120	3	14	14	NUM
njb-40	120	4	sah	sah	PROPN
njb-40	120	5	et	et	PROPN
njb-40	120	6	al	al	PROPN
njb-40	120	7	.	.	PUNCT
njb-40	121	1	©	©	PROPN
njb-40	121	2	njb	njb	PROPN
njb-40	121	3	,	,	PUNCT
njb-40	121	4	biotechnology	biotechnology	NOUN
njb-40	121	5	society	society	NOUN
njb-40	121	6	of	of	ADP
njb-40	121	7	nepal	nepal	ADJ
njb-40	121	8	14	14	NUM
njb-40	121	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	PROPN
njb-40	121	10	reported	report	VERB
njb-40	121	11	that	that	SCONJ
njb-40	121	12	when	when	SCONJ
njb-40	121	13	a	a	DET
njb-40	121	14	massive	massive	ADJ
njb-40	121	15	germ	germ	NOUN
njb-40	121	16	cell	cell	NOUN
njb-40	121	17	loss	loss	NOUN
njb-40	121	18	occurs	occur	VERB
njb-40	121	19	,	,	PUNCT
njb-40	121	20	it	it	PRON
njb-40	121	21	is	be	AUX
njb-40	121	22	followed	follow	VERB
njb-40	121	23	by	by	ADP
njb-40	121	24	a	a	DET
njb-40	121	25	sharp	sharp	ADJ
njb-40	121	26	decline	decline	NOUN
njb-40	121	27	in	in	ADP
njb-40	121	28	testicular	testicular	NOUN
njb-40	121	29	morphometric	morphometric	ADJ
njb-40	121	30	parameters	parameter	NOUN
njb-40	121	31	[	[	X
njb-40	121	32	13	13	NUM
njb-40	121	33	]	]	PUNCT
njb-40	121	34	.	.	PUNCT
njb-40	122	1	in	in	ADP
njb-40	122	2	general	general	ADJ
njb-40	122	3	,	,	PUNCT
njb-40	122	4	germ	germ	NOUN
njb-40	122	5	cell	cell	NOUN
njb-40	122	6	death	death	NOUN
njb-40	122	7	caused	cause	VERB
njb-40	122	8	by	by	ADP
njb-40	122	9	anticancer	anticancer	NOUN
njb-40	122	10	drugs	drug	NOUN
njb-40	122	11	,	,	PUNCT
njb-40	122	12	including	include	VERB
njb-40	122	13	doxorubicin	doxorubicin	PROPN
njb-40	122	14	,	,	PUNCT
njb-40	122	15	culminates	culminate	VERB
njb-40	122	16	with	with	ADP
njb-40	122	17	a	a	DET
njb-40	122	18	reduction	reduction	NOUN
njb-40	122	19	of	of	ADP
njb-40	122	20	morphometric	morphometric	ADJ
njb-40	122	21	parameters	parameter	NOUN
njb-40	122	22	[	[	PUNCT
njb-40	122	23	14	14	NUM
njb-40	122	24	]	]	PUNCT
njb-40	122	25	.	.	PUNCT
njb-40	123	1	many	many	ADJ
njb-40	123	2	of	of	ADP
njb-40	123	3	doxorubicin	doxorubicin	PROPN
njb-40	123	4	dose	dose	NOUN
njb-40	123	5	-	-	PUNCT
njb-40	123	6	limiting	limit	VERB
njb-40	123	7	toxicities	toxicity	NOUN
njb-40	123	8	occur	occur	VERB
njb-40	123	9	due	due	ADP
njb-40	123	10	to	to	ADP
njb-40	123	11	its	its	PRON
njb-40	123	12	generation	generation	NOUN
njb-40	123	13	of	of	ADP
njb-40	123	14	toxic	toxic	ADJ
njb-40	123	15	oxygen	oxygen	NOUN
njb-40	123	16	species	specie	NOUN
njb-40	123	17	,	,	PUNCT
njb-40	123	18	resulting	result	VERB
njb-40	123	19	in	in	ADP
njb-40	123	20	oxidative	oxidative	ADJ
njb-40	123	21	stress	stress	NOUN
njb-40	123	22	.	.	PUNCT
njb-40	124	1	in	in	ADP
njb-40	124	2	summary	summary	NOUN
njb-40	124	3	,	,	PUNCT
njb-40	124	4	present	present	ADJ
njb-40	124	5	study	study	NOUN
njb-40	124	6	reveals	reveal	VERB
njb-40	124	7	deteriorative	deteriorative	ADJ
njb-40	124	8	effect	effect	NOUN
njb-40	124	9	of	of	ADP
njb-40	124	10	doxorubicin	doxorubicin	PROPN
njb-40	124	11	on	on	ADP
njb-40	124	12	seminiferous	seminiferous	ADJ
njb-40	124	13	tubules	tubule	NOUN
njb-40	124	14	of	of	ADP
njb-40	124	15	rats	rat	NOUN
njb-40	124	16	.	.	PUNCT
njb-40	125	1	the	the	DET
njb-40	125	2	study	study	NOUN
njb-40	125	3	has	have	VERB
njb-40	125	4	however	however	ADV
njb-40	125	5	,	,	PUNCT
njb-40	125	6	several	several	ADJ
njb-40	125	7	limitations	limitation	NOUN
njb-40	125	8	.	.	PUNCT
njb-40	126	1	first	first	ADV
njb-40	126	2	,	,	PUNCT
njb-40	126	3	we	we	PRON
njb-40	126	4	did	do	AUX
njb-40	126	5	not	not	PART
njb-40	126	6	assess	assess	VERB
njb-40	126	7	the	the	DET
njb-40	126	8	ultrastructural	ultrastructural	ADJ
njb-40	126	9	changes	change	NOUN
njb-40	126	10	in	in	ADP
njb-40	126	11	testis	testis	NOUN
njb-40	126	12	caused	cause	VERB
njb-40	126	13	by	by	ADP
njb-40	126	14	doxorubicin	doxorubicin	PROPN
njb-40	126	15	.	.	PUNCT
njb-40	127	1	also	also	ADV
njb-40	127	2	,	,	PUNCT
njb-40	127	3	sperm	sperm	NOUN
njb-40	127	4	count	count	NOUN
njb-40	127	5	was	be	AUX
njb-40	127	6	not	not	PART
njb-40	127	7	done	do	VERB
njb-40	127	8	in	in	ADP
njb-40	127	9	this	this	DET
njb-40	127	10	study	study	NOUN
njb-40	127	11	.	.	PUNCT
njb-40	128	1	the	the	DET
njb-40	128	2	body	body	NOUN
njb-40	128	3	weight	weight	NOUN
njb-40	128	4	of	of	ADP
njb-40	128	5	the	the	DET
njb-40	128	6	experimental	experimental	ADJ
njb-40	128	7	rats	rat	NOUN
njb-40	128	8	fluctuated	fluctuate	VERB
njb-40	128	9	with	with	ADP
njb-40	128	10	the	the	DET
njb-40	128	11	duration	duration	NOUN
njb-40	128	12	.	.	PUNCT
njb-40	129	1	the	the	DET
njb-40	129	2	exact	exact	ADJ
njb-40	129	3	causes	cause	NOUN
njb-40	129	4	for	for	ADP
njb-40	129	5	the	the	DET
njb-40	129	6	fluctuation	fluctuation	NOUN
njb-40	129	7	of	of	ADP
njb-40	129	8	body	body	NOUN
njb-40	129	9	weight	weight	NOUN
njb-40	129	10	were	be	AUX
njb-40	129	11	not	not	PART
njb-40	129	12	identified	identify	VERB
njb-40	129	13	in	in	ADP
njb-40	129	14	this	this	DET
njb-40	129	15	study	study	NOUN
njb-40	129	16	.	.	PUNCT
njb-40	130	1	competing	compete	VERB
njb-40	130	2	interests	interest	NOUN
njb-40	130	3	none	none	NOUN
njb-40	130	4	author	author	NOUN
njb-40	130	5	’s	’s	PART
njb-40	130	6	contribution	contribution	NOUN
njb-40	130	7	sks	sk	NOUN
njb-40	130	8	,	,	PUNCT
njb-40	130	9	sk	sk	PROPN
njb-40	130	10	,	,	PUNCT
njb-40	130	11	dc	dc	PROPN
njb-40	130	12	,	,	PUNCT
njb-40	130	13	cbj	cbj	NOUN
njb-40	130	14	and	and	CCONJ
njb-40	130	15	sb	sb	PROPN
njb-40	130	16	designed	design	VERB
njb-40	130	17	the	the	DET
njb-40	130	18	study	study	NOUN
njb-40	130	19	.	.	PUNCT
njb-40	131	1	sks	sks	PROPN
njb-40	131	2	,	,	PUNCT
njb-40	131	3	sk	sk	PROPN
njb-40	131	4	and	and	CCONJ
njb-40	131	5	dc	dc	PROPN
njb-40	131	6	conducted	conduct	VERB
njb-40	131	7	the	the	DET
njb-40	131	8	experiments	experiment	NOUN
njb-40	131	9	.	.	PUNCT
njb-40	132	1	sks	sks	PROPN
njb-40	132	2	and	and	CCONJ
njb-40	132	3	sk	sk	PROPN
njb-40	132	4	wrote	write	VERB
njb-40	132	5	the	the	DET
njb-40	132	6	manuscript	manuscript	NOUN
njb-40	132	7	.	.	PUNCT
njb-40	133	1	dc	dc	PROPN
njb-40	133	2	,	,	PUNCT
njb-40	133	3	cbj	cbj	NOUN
njb-40	133	4	and	and	CCONJ
njb-40	133	5	sb	sb	PROPN
njb-40	133	6	reviewed	review	VERB
njb-40	133	7	manuscript	manuscript	NOUN
njb-40	133	8	.	.	PUNCT
njb-40	134	1	all	all	DET
njb-40	134	2	authors	author	NOUN
njb-40	134	3	read	read	VERB
njb-40	134	4	and	and	CCONJ
njb-40	134	5	approved	approve	VERB
njb-40	134	6	the	the	DET
njb-40	134	7	final	final	ADJ
njb-40	134	8	version	version	NOUN
njb-40	134	9	of	of	ADP
njb-40	134	10	manuscript	manuscript	NOUN
njb-40	134	11	.	.	PUNCT
njb-40	135	1	acknowledgements	acknowledgement	VERB
njb-40	135	2	we	we	PRON
njb-40	135	3	kindly	kindly	ADV
njb-40	135	4	acknowledge	acknowledge	VERB
njb-40	135	5	b	b	PROPN
njb-40	135	6	p	p	PROPN
njb-40	135	7	koirala	koirala	PROPN
njb-40	135	8	institute	institute	PROPN
njb-40	135	9	of	of	ADP
njb-40	135	10	health	health	PROPN
njb-40	135	11	sciences	science	NOUN
njb-40	135	12	for	for	ADP
njb-40	135	13	the	the	DET
njb-40	135	14	support	support	NOUN
njb-40	135	15	in	in	ADP
njb-40	135	16	the	the	DET
njb-40	135	17	study	study	NOUN
njb-40	135	18	.	.	PUNCT
njb-40	136	1	references	reference	NOUN
njb-40	136	2	1	1	NUM
njb-40	136	3	.	.	PUNCT
njb-40	137	1	atessahin	atessahin	PROPN
njb-40	137	2	a	a	DET
njb-40	137	3	,	,	PUNCT
njb-40	137	4	karahan	karahan	PROPN
njb-40	137	5	i	i	PROPN
njb-40	137	6	,	,	PUNCT
njb-40	137	7	turk	turk	PROPN
njb-40	137	8	g	g	PROPN
njb-40	137	9	,	,	PUNCT
njb-40	137	10	gur	gur	PROPN
njb-40	137	11	s	s	PROPN
njb-40	137	12	,	,	PUNCT
njb-40	137	13	yilmaz	yilmaz	PROPN
njb-40	137	14	s	s	PROPN
njb-40	137	15	,	,	PUNCT
njb-40	137	16	ceribasi	ceribasi	PROPN
njb-40	137	17	ao	ao	PROPN
njb-40	137	18	:	:	PUNCT
njb-40	137	19	protective	protective	ADJ
njb-40	137	20	role	role	NOUN
njb-40	137	21	of	of	ADP
njb-40	137	22	lycopene	lycopene	NOUN
njb-40	137	23	on	on	ADP
njb-40	137	24	cisplatin	cisplatin	NOUN
njb-40	137	25	induced	induce	VERB
njb-40	137	26	changes	change	NOUN
njb-40	137	27	in	in	ADP
njb-40	137	28	sperm	sperm	NOUN
njb-40	137	29	characteristics	characteristic	NOUN
njb-40	137	30	,	,	PUNCT
njb-40	137	31	testicular	testicular	NOUN
njb-40	137	32	damage	damage	NOUN
njb-40	137	33	and	and	CCONJ
njb-40	137	34	oxidative	oxidative	ADJ
njb-40	137	35	stress	stress	NOUN
njb-40	137	36	in	in	ADP
njb-40	137	37	rats	rat	NOUN
njb-40	137	38	.	.	PUNCT
njb-40	138	1	reprod	reprod	PROPN
njb-40	138	2	taxicol	taxicol	PROPN
njb-40	138	3	.	.	PROPN
njb-40	138	4	2006	2006	NUM
njb-40	138	5	21(1):42	21(1):42	NUM
njb-40	138	6	-	-	SYM
njb-40	138	7	7	7	NUM
njb-40	138	8	.	.	NUM
njb-40	138	9	2	2	NUM
njb-40	138	10	.	.	PUNCT
njb-40	138	11	rubin	rubin	PROPN
njb-40	138	12	p	p	PROPN
njb-40	138	13	,	,	PUNCT
njb-40	138	14	louis	louis	PROPN
njb-40	138	15	sc	sc	PROPN
njb-40	138	16	,	,	PUNCT
njb-40	138	17	lawrence	lawrence	PROPN
njb-40	138	18	bm	bm	PROPN
njb-40	138	19	,	,	PUNCT
njb-40	138	20	paul	paul	PROPN
njb-40	138	21	o.	o.	PROPN
njb-40	138	22	late	late	ADJ
njb-40	138	23	effect	effect	NOUN
njb-40	138	24	of	of	ADP
njb-40	138	25	cancer	cancer	NOUN
njb-40	138	26	treatment	treatment	NOUN
njb-40	138	27	on	on	ADP
njb-40	138	28	normal	normal	ADJ
njb-40	138	29	tissues	tissue	NOUN
njb-40	138	30	.	.	PUNCT
njb-40	139	1	springer	springer	PROPN
njb-40	139	2	verlog	verlog	PROPN
njb-40	139	3	,	,	PUNCT
njb-40	139	4	berlin	berlin	PROPN
njb-40	139	5	,	,	PUNCT
njb-40	139	6	heidelberg	heidelberg	PROPN
njb-40	139	7	.	.	PUNCT
njb-40	139	8	2008	2008	NUM
njb-40	140	1	1:109	1:109	NUM
njb-40	140	2	-	-	SYM
njb-40	140	3	30	30	NUM
njb-40	140	4	.	.	NUM
njb-40	140	5	3	3	X
njb-40	140	6	.	.	X
njb-40	140	7	yagmurcaa	yagmurcaa	PROPN
njb-40	140	8	m	m	PROPN
njb-40	140	9	,	,	PUNCT
njb-40	140	10	erdoganb	erdoganb	PROPN
njb-40	140	11	h	h	PROPN
njb-40	140	12	,	,	PUNCT
njb-40	140	13	irazc	irazc	PROPN
njb-40	140	14	m	m	PROPN
njb-40	140	15	,	,	PUNCT
njb-40	140	16	songurd	songurd	PROPN
njb-40	140	17	a	a	PROPN
njb-40	140	18	,	,	PUNCT
njb-40	140	19	ucare	ucare	PROPN
njb-40	140	20	m	m	PROPN
njb-40	140	21	,	,	PUNCT
njb-40	140	22	fadillioglu	fadillioglu	PROPN
njb-40	140	23	e	e	PROPN
njb-40	140	24	:	:	PUNCT
njb-40	140	25	caffeic	caffeic	ADJ
njb-40	140	26	acid	acid	NOUN
njb-40	140	27	phenethyl	phenethyl	NOUN
njb-40	140	28	ester	ester	NOUN
njb-40	140	29	as	as	ADP
njb-40	140	30	a	a	DET
njb-40	140	31	protective	protective	ADJ
njb-40	140	32	agent	agent	NOUN
njb-40	140	33	against	against	ADP
njb-40	140	34	doxorubicin	doxorubicin	PROPN
njb-40	140	35	nephrotoxicity	nephrotoxicity	NOUN
njb-40	140	36	in	in	ADP
njb-40	140	37	rats	rat	NOUN
njb-40	140	38	.	.	PUNCT
njb-40	141	1	clin	clin	PROPN
njb-40	141	2	chim	chim	PROPN
njb-40	141	3	acta	acta	PROPN
njb-40	141	4	.	.	PUNCT
njb-40	142	1	2004	2004	NUM
njb-40	142	2	348(1	348(1	NUM
njb-40	142	3	-	-	PUNCT
njb-40	142	4	2):27	2):27	NUM
njb-40	142	5	-	-	SYM
njb-40	142	6	34	34	NUM
njb-40	142	7	.	.	NUM
njb-40	142	8	4	4	NUM
njb-40	142	9	.	.	PUNCT
njb-40	143	1	sawada	sawada	PROPN
njb-40	143	2	t	t	PROPN
njb-40	143	3	,	,	PUNCT
njb-40	143	4	tamada	tamada	PROPN
njb-40	143	5	h	h	PROPN
njb-40	143	6	,	,	PUNCT
njb-40	143	7	mori	mori	PROPN
njb-40	143	8	j	j	NOUN
njb-40	143	9	:	:	PUNCT
njb-40	143	10	secretion	secretion	NOUN
njb-40	143	11	of	of	ADP
njb-40	143	12	testosterone	testosterone	NOUN
njb-40	143	13	and	and	CCONJ
njb-40	143	14	epidermal	epidermal	ADJ
njb-40	143	15	growth	growth	NOUN
njb-40	143	16	factor	factor	NOUN
njb-40	143	17	in	in	ADP
njb-40	143	18	mice	mouse	NOUN
njb-40	143	19	with	with	ADP
njb-40	143	20	oligozospermia	oligozospermia	NOUN
njb-40	143	21	caused	cause	VERB
njb-40	143	22	by	by	ADP
njb-40	143	23	doxorubicin	doxorubicin	PROPN
njb-40	143	24	hydrochloride	hydrochloride	PROPN
njb-40	143	25	.	.	PUNCT
njb-40	144	1	andrologia.1994	andrologia.1994	VERB
njb-40	145	1	26(3):151	26(3):151	NUM
njb-40	145	2	-	-	SYM
njb-40	145	3	3	3	NUM
njb-40	145	4	.	.	NUM
njb-40	145	5	5	5	NUM
njb-40	145	6	.	.	PUNCT
njb-40	146	1	quiles	quile	VERB
njb-40	146	2	jl	jl	PROPN
njb-40	146	3	,	,	PUNCT
njb-40	146	4	huertas	huertas	PROPN
njb-40	146	5	jr	jr	PROPN
njb-40	146	6	,	,	PUNCT
njb-40	146	7	battino	battino	PROPN
njb-40	146	8	m	m	PROPN
njb-40	146	9	,	,	PUNCT
njb-40	146	10	mataix	mataix	PROPN
njb-40	146	11	j	j	PROPN
njb-40	146	12	,	,	PUNCT
njb-40	146	13	ramíreztortosa	ramíreztortosa	PROPN
njb-40	146	14	mc	mc	PROPN
njb-40	146	15	:	:	PUNCT
njb-40	146	16	antioxidants	antioxidant	NOUN
njb-40	146	17	nutrients	nutrient	NOUN
njb-40	146	18	and	and	CCONJ
njb-40	146	19	adriamycin	adriamycin	PROPN
njb-40	146	20	toxicity	toxicity	NOUN
njb-40	146	21	.	.	PUNCT
njb-40	147	1	toxicology	toxicology	NOUN
njb-40	147	2	.	.	PUNCT
njb-40	148	1	2002	2002	NUM
njb-40	148	2	180(1):79	180(1):79	NUM
njb-40	148	3	-	-	SYM
njb-40	148	4	95	95	NUM
njb-40	148	5	.	.	NUM
njb-40	148	6	6	6	NUM
njb-40	148	7	.	.	PUNCT
njb-40	149	1	kobayashi	kobayashi	PROPN
njb-40	149	2	h	h	PROPN
njb-40	149	3	,	,	PUNCT
njb-40	149	4	urashima	urashima	PROPN
njb-40	149	5	m	m	PROPN
njb-40	149	6	,	,	PUNCT
njb-40	149	7	hoshi	hoshi	PROPN
njb-40	149	8	y	y	PROPN
njb-40	149	9	,	,	PUNCT
njb-40	149	10	uchiyama	uchiyama	PROPN
njb-40	149	11	h	h	PROPN
njb-40	149	12	,	,	PUNCT
njb-40	149	13	fujisawa	fujisawa	PROPN
njb-40	149	14	k	k	PROPN
njb-40	149	15	,	,	PUNCT
njb-40	149	16	akatsuka	akatsuka	PROPN
njb-40	149	17	j	j	X
njb-40	149	18	:	:	PUNCT
njb-40	149	19	testicular	testicular	ADJ
njb-40	149	20	morphological	morphological	ADJ
njb-40	149	21	changes	change	NOUN
njb-40	149	22	in	in	ADP
njb-40	149	23	children	child	NOUN
njb-40	149	24	with	with	ADP
njb-40	149	25	acute	acute	ADJ
njb-40	149	26	lymphoblastic	lymphoblastic	NOUN
njb-40	149	27	leukemia	leukemia	NOUN
njb-40	149	28	following	follow	VERB
njb-40	149	29	chemotherapy	chemotherapy	NOUN
njb-40	149	30	.	.	PUNCT
njb-40	150	1	pediatrics	pediatric	NOUN
njb-40	150	2	international	international	PROPN
njb-40	150	3	.	.	PUNCT
njb-40	151	1	1996	1996	NUM
njb-40	151	2	38:640	38:640	NUM
njb-40	151	3	-	-	SYM
njb-40	151	4	3	3	NUM
njb-40	151	5	.	.	NUM
njb-40	151	6	7	7	NUM
njb-40	151	7	.	.	X
njb-40	151	8	saalu	saalu	PROPN
njb-40	151	9	lc	lc	PROPN
njb-40	151	10	,	,	PUNCT
njb-40	151	11	enye	enye	PROPN
njb-40	151	12	la	la	PROPN
njb-40	151	13	,	,	PUNCT
njb-40	151	14	osinubi	osinubi	ADJ
njb-40	151	15	aa	aa	PROPN
njb-40	151	16	:	:	PUNCT
njb-40	151	17	an	an	DET
njb-40	151	18	assessment	assessment	NOUN
njb-40	151	19	of	of	ADP
njb-40	151	20	the	the	DET
njb-40	151	21	histomorphometric	histomorphometric	ADJ
njb-40	151	22	evidences	evidence	NOUN
njb-40	151	23	of	of	ADP
njb-40	151	24	doxorubicin	doxorubicin	PROPN
njb-40	151	25	-	-	PUNCT
njb-40	151	26	induced	induce	VERB
njb-40	151	27	testicular	testicular	NOUN
njb-40	151	28	cytotoxicity	cytotoxicity	NOUN
njb-40	151	29	in	in	ADP
njb-40	151	30	wistar	wistar	PROPN
njb-40	151	31	rats	rat	NOUN
njb-40	151	32	.	.	PUNCT
njb-40	152	1	int	int	PROPN
njb-40	152	2	j	j	PROPN
njb-40	152	3	med	med	PROPN
njb-40	152	4	med	med	PROPN
njb-40	152	5	sci	sci	PROPN
njb-40	152	6	.	.	PROPN
njb-40	152	7	2009	2009	NUM
njb-40	152	8	1(9):370	1(9):370	NUM
njb-40	152	9	-	-	SYM
njb-40	152	10	4	4	NUM
njb-40	152	11	.	.	NUM
njb-40	152	12	8	8	NUM
njb-40	152	13	.	.	PUNCT
njb-40	153	1	howell	howell	PROPN
njb-40	153	2	st	st	PROPN
njb-40	153	3	,	,	PUNCT
njb-40	153	4	shaler	shaler	PROPN
njb-40	153	5	sm	sm	NOUN
njb-40	153	6	:	:	PUNCT
njb-40	153	7	testicular	testicular	PROPN
njb-40	153	8	function	function	NOUN
njb-40	153	9	following	follow	VERB
njb-40	153	10	chemotherapy	chemotherapy	NOUN
njb-40	153	11	.	.	PUNCT
njb-40	154	1	hum	hum	NOUN
njb-40	154	2	reprod	reprod	PROPN
njb-40	154	3	.	.	PUNCT
njb-40	155	1	2001	2001	NUM
njb-40	155	2	7:363	7:363	NUM
njb-40	155	3	-	-	SYM
njb-40	155	4	9	9	NUM
njb-40	155	5	.	.	NOUN
njb-40	155	6	9	9	NUM
njb-40	155	7	.	.	PUNCT
njb-40	155	8	prahalathan	prahalathan	PROPN
njb-40	155	9	c	c	PROPN
njb-40	155	10	,	,	PUNCT
njb-40	155	11	selvakumar	selvakumar	PROPN
njb-40	155	12	e	e	PROPN
njb-40	155	13	,	,	PUNCT
njb-40	155	14	varalakshmi	varalakshmi	PROPN
njb-40	155	15	p	p	PROPN
njb-40	155	16	:	:	PUNCT
njb-40	155	17	lipoic	lipoic	PROPN
njb-40	155	18	acid	acid	PROPN
njb-40	155	19	ameliorates	ameliorate	VERB
njb-40	155	20	adriamycininduced	adriamycininduced	ADJ
njb-40	155	21	testicular	testicular	NOUN
njb-40	155	22	mitochondriopathy	mitochondriopathy	PROPN
njb-40	155	23	.	.	PUNCT
njb-40	156	1	reprod	reprod	PROPN
njb-40	156	2	toxicol	toxicol	PROPN
njb-40	156	3	.	.	PROPN
njb-40	156	4	2005	2005	NUM
njb-40	156	5	20:111	20:111	NUM
njb-40	156	6	-	-	SYM
njb-40	156	7	6	6	NUM
njb-40	156	8	.	.	NUM
njb-40	156	9	10	10	NUM
njb-40	156	10	.	.	PUNCT
njb-40	157	1	patil	patil	PROPN
njb-40	157	2	l	l	PROPN
njb-40	157	3	,	,	PUNCT
njb-40	157	4	r.	r.	PROPN
njb-40	157	5	balaraman	balaraman	PROPN
njb-40	157	6	r	r	PROPN
njb-40	157	7	:	:	PUNCT
njb-40	157	8	effect	effect	NOUN
njb-40	157	9	of	of	ADP
njb-40	157	10	melatonin	melatonin	NOUN
njb-40	157	11	on	on	ADP
njb-40	157	12	doxorubicin	doxorubicin	PROPN
njb-40	157	13	induced	induce	VERB
njb-40	157	14	testicular	testicular	NOUN
njb-40	157	15	damage	damage	NOUN
njb-40	157	16	in	in	ADP
njb-40	157	17	rats	rat	NOUN
njb-40	157	18	.	.	PUNCT
njb-40	158	1	2009	2009	NUM
njb-40	158	2	1(3):879	1(3):879	NUM
njb-40	158	3	-	-	SYM
njb-40	158	4	84	84	NUM
njb-40	158	5	.	.	NUM
njb-40	158	6	11	11	NUM
njb-40	158	7	.	.	PUNCT
njb-40	159	1	jahnukainen	jahnukainen	PROPN
njb-40	159	2	k	k	PROPN
njb-40	159	3	,	,	PUNCT
njb-40	159	4	hou	hou	PROPN
njb-40	159	5	m	m	PROPN
njb-40	159	6	,	,	PUNCT
njb-40	159	7	parvinen	parvinen	NOUN
njb-40	159	8	m	m	PROPN
njb-40	159	9	,	,	PUNCT
njb-40	159	10	eksborg	eksborg	PROPN
njb-40	159	11	s	s	PROPN
njb-40	159	12	,	,	PUNCT
njb-40	159	13	söder	söder	NOUN
njb-40	159	14	o	o	PROPN
njb-40	159	15	:	:	PUNCT
njb-40	159	16	stage	stage	NOUN
njb-40	159	17	-	-	PUNCT
njb-40	159	18	specific	specific	ADJ
njb-40	159	19	inhibition	inhibition	NOUN
njb-40	159	20	of	of	ADP
njb-40	159	21	deoxyribonucleic	deoxyribonucleic	ADJ
njb-40	159	22	acid	acid	NOUN
njb-40	159	23	synthesis	synthesis	NOUN
njb-40	159	24	and	and	CCONJ
njb-40	159	25	induction	induction	NOUN
njb-40	159	26	of	of	ADP
njb-40	159	27	apoptosis	apoptosis	NOUN
njb-40	159	28	by	by	ADP
njb-40	159	29	antracyclines	antracycline	NOUN
njb-40	159	30	in	in	ADP
njb-40	159	31	cultured	cultured	ADJ
njb-40	159	32	rat	rat	NOUN
njb-40	159	33	spermatogenic	spermatogenic	ADJ
njb-40	159	34	cells	cell	NOUN
njb-40	159	35	.	.	PUNCT
njb-40	160	1	biol	biol	PROPN
njb-40	160	2	reprod	reprod	PROPN
njb-40	160	3	.	.	PUNCT
njb-40	161	1	2000	2000	NUM
njb-40	161	2	63(2):482	63(2):482	PROPN
njb-40	161	3	-	-	SYM
njb-40	161	4	7	7	NUM
njb-40	161	5	.	.	NUM
njb-40	161	6	12	12	NUM
njb-40	161	7	.	.	PUNCT
njb-40	161	8	vendramini	vendramini	PROPN
njb-40	161	9	v	v	PROPN
njb-40	161	10	,	,	PUNCT
njb-40	161	11	sasso	sasso	NOUN
njb-40	161	12	-	-	PUNCT
njb-40	161	13	cerri	cerri	PROPN
njb-40	161	14	e	e	PROPN
njb-40	161	15	,	,	PUNCT
njb-40	161	16	miraglia	miraglia	PROPN
njb-40	161	17	sm	sm	NOUN
njb-40	161	18	:	:	PUNCT
njb-40	161	19	amifostine	amifostine	NOUN
njb-40	161	20	reduces	reduce	VERB
njb-40	161	21	the	the	DET
njb-40	161	22	seminiferous	seminiferous	ADJ
njb-40	161	23	epithelium	epithelium	NOUN
njb-40	161	24	damage	damage	NOUN
njb-40	161	25	in	in	ADP
njb-40	161	26	doxorubicin	doxorubicin	PROPN
njb-40	161	27	-	-	PUNCT
njb-40	161	28	treated	treat	VERB
njb-40	161	29	prepubertal	prepubertal	ADJ
njb-40	161	30	rats	rat	NOUN
njb-40	161	31	without	without	ADP
njb-40	161	32	improving	improve	VERB
njb-40	161	33	the	the	DET
njb-40	161	34	fertility	fertility	NOUN
njb-40	161	35	status	status	NOUN
njb-40	161	36	.	.	PUNCT
njb-40	162	1	reprod	reprod	PROPN
njb-40	162	2	biol	biol	PROPN
njb-40	162	3	endocrinol	endocrinol	NOUN
njb-40	162	4	.	.	PUNCT
njb-40	163	1	2010	2010	NUM
njb-40	163	2	8:3	8:3	NUM
njb-40	163	3	.	.	PUNCT
njb-40	164	1	13	13	NUM
njb-40	164	2	.	.	PUNCT
njb-40	164	3	franca	franca	NOUN
njb-40	164	4	lr	lr	PROPN
njb-40	164	5	,	,	PUNCT
njb-40	164	6	russel	russel	PROPN
njb-40	164	7	ld	ld	PROPN
njb-40	164	8	:	:	PUNCT
njb-40	164	9	the	the	DET
njb-40	164	10	testis	testis	NOUN
njb-40	164	11	of	of	ADP
njb-40	164	12	domestic	domestic	ADJ
njb-40	164	13	animals	animal	NOUN
njb-40	164	14	.	.	PUNCT
njb-40	165	1	in	in	ADP
njb-40	165	2	:	:	PUNCT
njb-40	165	3	martínez	martínez	PROPN
njb-40	165	4	-	-	PUNCT
njb-40	165	5	garcia	garcia	PROPN
njb-40	165	6	f	f	PROPN
njb-40	165	7	,	,	PUNCT
njb-40	165	8	regadera	regadera	PROPN
njb-40	165	9	j	j	PROPN
njb-40	165	10	,	,	PUNCT
njb-40	165	11	eds	eds	PROPN
njb-40	165	12	.	.	PUNCT
njb-40	166	1	male	male	ADJ
njb-40	166	2	reproduction	reproduction	NOUN
njb-40	166	3	:	:	PUNCT
njb-40	166	4	a	a	DET
njb-40	166	5	multidisciplinary	multidisciplinary	ADJ
njb-40	166	6	overview	overview	NOUN
njb-40	166	7	.	.	PUNCT
njb-40	167	1	churchill	churchill	PROPN
njb-40	167	2	communications	communications	PROPN
njb-40	167	3	,	,	PUNCT
njb-40	167	4	madrid	madrid	PROPN
njb-40	167	5	.	.	PUNCT
njb-40	168	1	1998	1998	NUM
njb-40	168	2	:	:	PUNCT
njb-40	168	3	198	198	NUM
njb-40	168	4	-	-	SYM
njb-40	168	5	219	219	NUM
njb-40	168	6	.	.	PUNCT
njb-40	168	7	14	14	NUM
njb-40	168	8	.	.	PUNCT
njb-40	169	1	stumpp	stumpp	PROPN
njb-40	169	2	t	t	PROPN
njb-40	169	3	,	,	PUNCT
njb-40	169	4	sasso	sasso	PROPN
njb-40	169	5	-	-	PUNCT
njb-40	169	6	cerri	cerri	PROPN
njb-40	169	7	e	e	PROPN
njb-40	169	8	,	,	PUNCT
njb-40	169	9	freymuller	freymuller	PROPN
njb-40	169	10	e	e	PROPN
njb-40	169	11	,	,	PUNCT
njb-40	169	12	miraglia	miraglia	PROPN
njb-40	169	13	sm	sm	NOUN
njb-40	169	14	:	:	PUNCT
njb-40	169	15	apoptosis	apoptosis	NOUN
njb-40	169	16	and	and	CCONJ
njb-40	169	17	testicular	testicular	NOUN
njb-40	169	18	alterations	alteration	NOUN
njb-40	169	19	in	in	ADP
njb-40	169	20	albino	albino	NOUN
njb-40	169	21	rats	rat	NOUN
njb-40	169	22	treated	treat	VERB
njb-40	169	23	with	with	ADP
njb-40	169	24	etoposide	etoposide	NOUN
njb-40	169	25	during	during	ADP
njb-40	169	26	the	the	DET
njb-40	169	27	prepubertal	prepubertal	ADJ
njb-40	169	28	phase	phase	NOUN
njb-40	169	29	.	.	PUNCT
njb-40	170	1	anat	anat	PROPN
njb-40	170	2	rec	rec	PROPN
njb-40	170	3	.	.	PUNCT
njb-40	171	1	2004	2004	NUM
njb-40	171	2	279:611	279:611	NUM
njb-40	171	3	-	-	SYM
njb-40	171	4	22	22	NUM
njb-40	171	5	.	.	PUNCT